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ABSTRACT OF DISSERTATION 
 
 
 
 
ROLE OF THE REACTIVE OXYGEN SPECIES PEROXYNITRITE IN 
TRAUMATIC BRAIN INJURY 
 
 Reactive oxygen species (ROS) is cytotoxic to the cell and is known to 
contribute to secondary cell death following primary traumatic brain injury (TBI). 
We described in our study that PN is the main mediator for both lipid peroxidation 
and protein nitration, and occurred almost immediately after injury. As a 
downstream factor to oxidative damage, the peak of Ca2+-dependent, calpain-
mediated cytoskeletal proteolysis preceded that of neurodegeneration, 
suggesting that calpain-mediated proteolysis is the common pathway leading to 
neuronal cell death. The time course study clearly elucidated the interrelationship 
of these cellular changes following TBI, provided window of opportunity for 
pharmacological intervention.   
 Furthermore, we conducted a pharmacological study to solidify our 
hypothesis. First of all, we tested the potency of a membrane permeable, 
catalytic scavenger of PN-derived free radicals, tempol for its ability to 
antagonize PN-induced oxidative damage. Tempol successfully inhibited PN-
induced protein nitration at dosages of 30, 100 and 300mg/kg. Moreover, early 
single dose of 300mg/kg was administered and isolated mitochondria were 
examined for respiratory function and oxidative damage level. Our data showed 
that tempol reduced mitochondrial oxidative damage, and maintained 
mitochondrial function within normal limits, which suggested that tempol is 
efficiently permeable to mitochondrial membrane and mitochondrial oxidative 
damage is essential to mitochondrial dysfunction. Next, we found that calpain-
mediated proteolysis is reduced at early treatment with a single dose of tempol. 
However, the effect of tempol on calpain is short-lived possibly due to systematic 
elimination. In our multiple dose study, tempol showed a significant inhibitory 
effect on SBDPs. Consequently, we measured neuordegeneration with the de 
Olmos aminocupric silver staining method at 7 days post-injury and detected a 
significant decrease of neuronal cell death.  
 Together, the time course study and pharmacological study strongly 
support the hypothesis that PN is the upstream mediator in secondary cell death 
in the CCI TBI mouse model. Moreover, inhibition of PN-mediated oxidative 
damage with the antioxidant, tempol, is able to attenuate multiple downstream 
injury mechanisms. However, targeting PN alone may be clinically impractical 
due to its limited therapeutic window. This limitation may be overcome in future 
studies by a combination of multiple therapeutic strategies.  
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dysfunction, Calpain-Mediated Proteolysis   
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Chapter One 
Post-Traumatic Secondary Injury in Experimental Traumatic Brain Injury 
 
Free Radicals Production and Oxidative Damage in Traumatic Brain Injury 
 
Introduction 
Oxygen is necessary for life. However, only about 85-90% of the O2 taken 
up by mammalian cells is effectively utilized by their mitochondria for energy 
production. The remainder is converted to highly toxic reactive oxygen species 
(ROS) and their derived oxygen radicals which are damaging to cells. Following 
acute traumatic brain injury (TBI), oxidative stress leading to the formation of 
ROS and free radicals and oxidative alteration of brain tissue has been 
implicated as a common pathway following excitotoxicity. Excitotoxicity begins  
immediately after TBI, in which excessive excitatory amino acid, such as 
glutamate, is released into extracellular spaces and over-activates glutamate 
receptors, thereby inducing abnormal calcium influx (Faden, Demediuk et al. 
1989). Moreover, other investigators showed that there is a prompt increase in 
free radicals that is essentially coincident with the release of glutamate proximate 
to the injury site, and there is a close correlation between the magnitudes of both 
events, suggesting that these two processes are part of a common pathways 
(Globus, Alonso et al. 1995). Furthermore, in vitro cortical cell culture studies 
showed that application of free radical scavengers or antioxidant compounds 
reduces glutamate-mediated excitotoxicity providing additional support for the 
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role of oxidative stress and damage mechanisms in excitotoxicity (Monyer, 
Hartley et al. 1990). However, oxidative stress is not the only component of post-
traumatic cell death. Growing evidence has indicated that post-traumatic free 
radical production is linked to disruption of intracellular calcium (Ca2+) 
homeostasis, induction of mitochondrial dysfunction and loss of Ca2+ buffering 
capacity and downstream activation of the Ca2+-dependent protease, calpain, 
which can proteolytically dismantle cellular structure.   
Brain tissue is particularly vulnerable to oxidative damage due to its high 
metabolic requirement for oxygen; its prevalent concentration of oxidizable 
polyunsaturated fatty acids (PUFAs) in membranes; its enrichment in redox 
active metals, most notably iron and the presence of potentially phagocytic 
microglia which can become a major source of ROS and free radicals when 
activated by injury. The high content of free radical-sensitive PUFAs in the 
membrane lipids of neurons and myelin provides the target for free radical-
induced lipid peroxidation (LP), in which a single free radical can trigger a chain 
reaction in the lipid bilayer that is potentiated by transition metal ions (Hall and 
Braughler 1993; Watson 1993).  
Experimental TBI models have provided compelling evidence supporting 
the important role of ROS and LP in the pathophysiology of acute TBI. The first 
work showing this was provided by Kontos and his colleagues who demonstrated 
an almost immediate post-injury increase in brain microvascular superoxide 
radical production in fluid percussion injury (FPI) TBI model (Kontos and 
Povlishock 1986; Kontos and Wei 1986). Moreover, hydroxyl radical was shown 
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to increase during the first minutes after injury (Hall, Andrus et al. 1993), followed 
in close succession by increased LP, blood-brain barrier (BBB) disruption and 
edema (Smith, Andrus et al. 1994; Nishio, Yunoki et al. 1997; Kasprzak, Wozniak 
et al. 2001). In addition to that, evidences from addition of exogenous 
antioxidants and transgenic studies further suggest oxidative damage as a 
potential therapeutic target (Hall and Smith 1991; Smith, Andrus et al. 1994; 
Chan, Epstein et al. 1995; Mikawa, Kinouchi et al. 1996; Hall, Kupina et al. 
1999). 
 
Definition of Free Radical and ROS 
As defined by Halliwell and Gutteridge, a free radical is any species 
capable of independent existence (hence the “free”) that contains one or more 
unpaired electrons. Free radicals may be mono- or poly-atomic. It is important to 
know that not all free radicals are highly reactive. Reactive oxygen species 
(ROS) is a collective term often used by scientists to include not only the oxygen 
radicals (O2• ⎯ and •OH), but also some non-radical derivatives of O2 such as 
hydrogen peroxide (H2O2). Therefore, some ROS are not necessarily a free 
radical themselves, but are molecules that can generate free radicals (Halliwell 
and Gutteridge et al, 1985). Moreover, some oxides of nitrogen are alternatively 
termed reactive nitrogen species (RNS), such as nitric oxide (NO•) and 
peroxynitrite anion (ONOO⎯).  
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Oxygen as a Source of ROS 
After brain injury, ROS and/or free radicals may be generated through 
several different cellular pathways, such as the free radical leak from 
mitochondria respiratory chain; nitric oxide synthases (NOSs); conversion of 
xanthine dehydrogenase (XDH) to xanthine oxidase (XO); phospholipase A2-
cyclooxygenase pathway; Fenton and Haber-Weiss reactions by inflammatory 
cells (Gutteridge and Halliwell 1989; Kehrer 2000). Moreover, a number of 
enzymes, such as cytochromes P450, various oxidases, peroxidases, 
lipoxygenases and dehydrogenases can be sources of ROS.  
Oxygen is the most abundant molecule in a biological system. It exists as 
a di-radical and therefore is very reactive with radicals. Although oxygen can act 
as an oxidizing agent, its two unpaired electrons remain at most stable state. 
Thus O2 normally accepts one electron at a time, reacts sluggishly with non-
radicals. As it is partially reduced through normal metabolic processes, oxygen is 
often the source of free radicals. The escape of the free radicals normally is 
counteracted by endogenous antioxidant system. However, under pathological 
conditions, over-production of oxygen-derived ROS and free radicals overwhelms 
the endogenous antioxidants, inducing “oxidative stress”. If the imbalance of the 
pro- and anti-oxidant system occurs, this leads to degradation or modification of 
macromolecules (e.g. lipids, proteins, nucleic acids) and irreversible impairment 
of their function, it is termed as “oxidative damage”. 
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Superoxide Radical  
One of the most important sources of superoxide radical (O2• ⎯) in vivo is 
the mitochondrial electron transport chain (ETC). Estimated up to 1% of total 
mitochondrial oxygen consumption goes toward the production of superoxide or 
hydrogen peroxide at intermediate steps of the mitochondrial ETC (Ischiropoulos 
and Beckman 2003). It is believed that mono electron reduction of oxygen into 
superoxide primarily occurs at ETC complex I (NADH dehydrogenase) level and 
coenzyme Q level (ubiquinone-cytochrome b)  (Kowaltowski and Vercesi 1999). 
(Figure 1.1) 
 
 
Succinate     Fumarate 
 
 
Figure 1.1 Simplified schematic of superoxide production from ETC. 
 
 
Complex I 
Matrix Complex II 
Complex Complex III IV 
NADH 
 DH 
UQ• ⎯         UQ 
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NADH NAD 
O2• ⎯ O2
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Theoretically, superoxide radical can be generated from oxygen through 
mono electron reduction at all components of the respiratory chain. However, the 
NADH dehydrogenase and ubiquinone-cytochrome b appear to be the two 
primary O2• ⎯ generation sites (Turrens and Boveris 1980). Although complex IV 
catalyses four sequential 1e⎯ additions to molecular oxygen, the intermediates 
are tightly retained, and there is no leakage of superoxide occurs (Nicholls and 
Ferguson et al. 2002). Physiologically, electrons are transferred from NADH to 
the oxidized form of ubiquinone (UQ) to yield the reduced form of ubiquinone and 
ubiquinol (UQH2). During the course when UQH2 transferring the electron to 
cytochrome c oxdiase, it is converted to firstly intermediate free radical 
semiquinone anion species (UQ• ⎯), and then back to UQ. This process initially 
occurs on cytoplasmic face of the inner mitochondrial membrane (IMM), and is 
then repeated on the matrix face of the IMM. Myxothiazol inhibits UQH2 at the 
cytoplasmic face of the IMM, therefore blocks the formation of UQ• ⎯, and 
stimulates O2• ⎯ formation only at the level of NADH dehydrogenase; whereas 
antimycin A inhibits UQ• ⎯ formation at cytoplasmic face, thereby accumulates 
UQ• ⎯ at matrix face of the IMM, resulting in stimulating O2• ⎯ formation at both the 
level of NADH dehydrogenase and coenzyme Q. Therefore, some hypothesize 
that mitochondrial generated O2• ⎯ preferably occurs at the lever of coenzyme Q 
(Kowaltowski, Castilho et al. 1995). In contrast to that, complex I level of O2• ⎯ 
generation is more ∆Ψm dependent. However, the precise nature of the O2• ⎯ 
production site in complex I remain arguable. Complex I inhibitor rotenone 
generates O2• ⎯ during electron transport through the complex from NAD+-linked 
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substrates. Even with the absence of endogenous complex I substrates and with 
succinate (complex II substrate), complex I can still generate O2• ⎯ as a result of 
reversed electron transfer (Turrens and Boveris 1980). Therefore, NADH 
dehydrogenase remains a notable site of O2• ⎯ generation.  
Some O2• ⎯ is also produced by activated phagocytic cells. Activated 
phagocytic cells are capable of reducing O2 into O2• ⎯ through the activity of 
NADPH oxidase (Bianca, Dusi et al. 1999; Gao, Jiang et al. 2002). Another 
source is the largely endothelial cell-contained xanthine oxidase (McCord 1987). 
Most of the xanthine/hypoxanthine oxidation in vivo is catalysed by xanthine 
dehydrogenase, which transfers electrons from the substrates onto NAD+ rather 
than to O2.  
Xanthine/hypoxanthine Uric acid 
Xanthine dehydrogenase + + 
NAD+ NADH 
However, under ischemic and post-ischemic reoxygenation conditions, xanthine 
dehydrogenase can be converted into xanthine oxidase by oxidation and 
therefore produce O2• ⎯ and H2O2 while oxidizing xanthine or hypoxanthine. In 
addition to that, depletion of adenosine triphosphate (ATP) in hypoxic tissues 
results in accumulation of hypoxanthine. Hypoxanthine can be oxidized by 
xanthine oxidase when tissue are reoxygenated, causing rapid generation of O2• ⎯ 
and H2O2.  
Superoxide radical can also be produced by heme proteins. Normally, the 
iron in the heme rings of the hemoglobin or myoglobin remains in the ferrous 
state (Fe2+) for O2 binding. However, some delocalization of the electron takes 
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place and results in an intermediate structure, producing ferric iron (Fe3+) in the 
heme ring. Ferric iron present in the heme ring is inactive and unable to bind O2, 
thereby releases a molecule of superoxide radical:  
Heme–Fe2+–O2 ↔ heme–Fe3+–O2• ⎯ → O2• ⎯ + heme–Fe3+  
Moreover, superoxide can be produced from arachidonic acid cascade 
through prostaglandin hydroperoxidase (PGH) and 5-lipoxygenase activity as a 
side-chain reaction depending on the presence of NADH or NADPH (Kukreja, 
Kontos et al. 1986).  
There are several important biological oxidations in the presence of O2  
that result in O2• ⎯, such as glyceraldehyde, FMNH2, FADH2, the hormones 
adrenalin and noradrenalin, L-DOPA (dihydroxyphenylalanine), the 
neurotransmitter dopamine, tetrahydropteridines and thiol compounds (eg. 
cysteine) (Davis, Kaufman et al. 1988). Most of these reactions are accelerated 
by transition metals since O2 is poorly reactive. 
More interestingly, Ca2+ influx was suggested to be a source of 
mitochondrial O2• ⎯ as well, in which Ca2+ leads to IMM alteration and 
disorganization of the ETC (Kowaltowski, Castilho et al. 1995). Grijalba et al 
proposed that Ca2+ alters the lipid organization of IMM by interacting with the 
anionic head of cardiolipin, which is an abundant component of IMM. As a result, 
the function of the ETC was affected, such as coenzyme Q mobility, leading to 
mono-electronic oxygen reduction at intermediate steps of respiration, which 
promote the production of O2• ⎯ (Grijalba, Vercesi et al. 1999). 
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To this end, superoxide can reduce the endogenous antioxidant enzyme 
reservoir by direct reaction, such as with catalase and glutathione peroxidase, as 
well as enzymes involved in energy metabolism (Zhang, Marcillat et al. 1990). 
Nevertheless, neither O2• ⎯ nor H2O2 is sufficiently reactive to account for much of 
the post-traumatic oxidative damage found in vivo. It is known that superoxide-
derived species are much more cytotoxic than superoxide itself.  
 
Superoxide-Derived Species  
Hydroperoxyl radical: While O2• ⎯ may act as an oxidant or reductant, and 
is reactive with radicals, for example, reduce Fe3+ to Fe2+, it is relatively inert in 
reaction with non-radicals in aqueous environments. In solution, superoxide 
exists in equilibrium with its protonated form, hydroperoxyl radical (HO2•). Under 
conditions of tissue acidosis occur within severely injured nervous system, O2• ⎯ 
exists mostly as HO2•, which is more reactive and capable of initiating LP 
(Halliwell, Gutteridge et al, 1985). In contrast to the exceedingly slow rate of 
dismutation of O2• ⎯ to H2O2, HO2• is much more readily able to generate H2O2 
(Hall and Braughler 1993).  
O2• ⎯ + H+ → HO2• 
Hydrogen peroxide: Dismutation of O2• ⎯ by superoxide dismutase (SOD) 
generates hydrogen peroxide (H2O2). SOD is an important antioxidant enzyme 
and specific for O2• ⎯ as a substrate. However, H2O2 is poorly reactive at 
physiological level. H2O2 is usually removed by two types of enzymes: catalases 
and peroxidases. The catalases directly catalyse decomposition of H2O2 to O2:   
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2 H2O2 → 2 H2O + O2. Peroxidase enzymes remove H2O2 by using it to oxidize 
another substrate: SH2 + H2O2 → S + 2H2O. In the case of glutathione 
peroxidase (GPX), it removes H2O2 by coupling its reduction to H2O with 
oxidation of reduced glutathione (GSH): H2O2 + 2GSH → GSSG + 2H2O. Both 
catalases and GPX enzymes are widely distributed in animal tissues readily to 
produce H2O2.  
Hydroxyl radical: Hydroxyl radical (•OH) is an extremely reactive form of 
free radicals produced from H2O2 by the metal-catalyzed Fenton reaction; or in 
the presence of  O2• ⎯ and catalytic amounts of transition medals, from the metal-
catalyzed Haber-Weiss reaction (Gutteridge and Halliwell 1989).  
Mitochondria 
O2• ⎯               H2O2 + Fe2+               Fe3+ + OH⎯ + •OH          Oxidative damage 
SOD 
Phagocytes Action of O2           O2• ⎯ Other enzymes 
 
Hydroxyl radical can also be produced from peroxynitrite (PN), a ROS generated 
by reaction between nitric oxide (NO•) and superoxide radical (O2• ⎯) (Radi, 
Beckman et al. 1991). Hydroxyl radical was detected within half an hour after 
trauma through the use of trapping agents such as salicylate (Hall, Andrus et al. 
1993) or nitrone spin traps (Sen and Phillis 1993; Sen, Goldman et al. 1994). The 
formation of highly reactive •OH became widely accepted as the primary 
mechanism of free radical toxicity. Although •OH is capable of destroying various 
bio-molecules, the reaction with organic molecules is diffusion rate-limited, 
ranging from 109 to 1010 M-1•s-1. Therefore, it will react as fast as it is formed and 
cannot explain any form of oxidative damage that occurs remote from its site of 
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formation. Thus, Its “non-discriminative” nature makes •OH attack uncritical 
targets and quickly be removed from the system (Hall and Braughler 1993; 
Beckman 1994; Crow and Beckman 1996).  
 Peroxynitrite: To better understand the toxicity of oxidative damage, an 
oxidant that is able to out-compete endogenous antioxidant defenses is proposed 
to be peroxynitrite (Blou 1985; Beckman 1994). Peroxynitrite (PN) refers to 
peroxynitrite anion (ONOO⎯) as well as its conjugate acid, peroxynitrous acid 
(ONOOH). PN is produced by the very fast reaction of O2• ⎯ with NO•. 
Interestingly, O2• ⎯ is one of the few molecules that reacts with NO• quickly. PN 
can generate a wide range of noxious free radical species  under physiological 
conditions. Superoxide radical and nitric oxide react readily at rate of 6.7 × 109 M-
1•s-1, which is at least three times faster than SOD reacts with O2• ⎯, and at least 
ten times faster than heme compounds react with NO•. Therefore, NO• and O2• ⎯  
can antagonize each other’s biological actions (Cudd and Fridovich 1982; Huie 
and Padmaja 1993). 
  NO• + O
 •
2  ⎯           ONOO⎯       k  ≈  7 × 109 M-1•s-1
In humans, NO• is formed from arginine, O2 and NADPH by nitric oxide 
synthases (NOSs) and functions as a diffusible messenger to modulate neuronal 
signaling following excitotoxicity (Garthwaite, Charles et al. 1988), regulate 
vascular tone, and kill pathogens (Bredt and Snyder 1990; Bredt and Snyder 
1994).  
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Arginine                    hydroxy-arginine                      citrulline + NO• 
NADPH ½ NADPH 
  O2       
     H2O                          O2          H2O 
There are three identified isoforms of NOS, which are endothelial NOS (eNOS), 
neuronal (nNOS) and inducible (iNOS), all of which appear to be involved in TBI 
pathology. For instance, it was shown in a lateral FPI model, that there was a 
pronounced eNOS increase in microvessels surrounding the cortical contusion at 
24 hrs after injury which was associated with BBB breakdown and hyperemia 
(Cobbs, Fenoy et al. 1997). Moreover, studies using NOS inhibitors showed 
reduced neurological deficit, which suggested a possible important pathological 
role of NO• and PN in neurodegeneration following TBI. However, the drug 
effects appeared to be time dependent and showed a limited therapeutic time 
window after injury (Mesenge, Verrecchia et al. 1996; Wada, Chatzipanteli et al. 
1998). In comparison to that, iNOS activity was also shown to be significantly 
increased, and improved histopathological outcome has been reported following 
inhibition of iNOS in a FPI model (Wada, Chatzipanteli et al. 1998). Nevertheless, 
the levels of all three NOS appeared to have different temporal and spatial 
profiles, indicating the compartmentalization of nitric oxide can be beneficial or 
detrimental (Gahm, Holmin et al. 2000; Orihara, Ikematsu et al. 2001). In recent 
years, a novel isoform of NOS was described located within mitochondria, named 
mitochondrial NOS (mtNOS) (Bates, Loesch et al. 1995; Lopez-Figueroa, 
Caamano et al. 2000). It was suggested to play a role in calcium release by 
formation of intramitochondrial PN through thiol cross-linking and NAD+ 
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hydrolysis to prevent calcium overload (Bringold, Ghafourifar et al. 2000). 
However, overproduction of intramitochondrial NO•-derived PN was indicated to 
induce irreversible damage to neuron-mitochondrial complex (Stewart, Sharpe et 
al. 2000). 
PN has relative long half-life compared to other ROS (~1sec), and it can 
diffuse across membrane, which enable PN to induce oxidative damage remote 
from its site of formation. The protonated form of PN (around neutral pH), 
peroxynitrous acid (ONOOH), is a strong oxidizing species. ONOOH is unstable 
and quickly releases nitrogen dioxide (•NO2) and hydroxyl radical (•OH). 
Moreover, PN can also react with carbon dioxide (CO2) to form nitrosoperoxo 
carbonate (ONOOCO2), then breaks down into nitrogen dioxide (•NO2) and 
carbonate radical (CO3• ⎯). PN-derived radicals are extremely potent and react 
rapidly with bio-molecules (Murphy, Packer et al. 1998; Radi 1998; Hall, Detloff et 
al. 2004). (Figure 1.2)  
One of the most studied reactions involved in PN biochemistry concerns 
the conversion of 3 position tyrosine to 3-nitrotyrosine (3NT), in which PN-derived 
•NO2 nitrates aromatic compounds, which is widely used as a bioassay to detect 
ONOO⎯ in vivo (Beckman 1996). In addition to that, PN-derived radicals can 
induce LP which produces various aliphatic aldehydic products which bind to 
cellular proteins and be measured by immunohistochemistry (Hall, Oostveen et 
al. 1997; Hall, Detloff et al. 2004). Moreover, 4-hydroxynonenal (4HNE) is the 
most cytotoxic LP-derived aldehydes (Keller, Mark et al. 1997). 
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Figure 1.2 Biochemistry of ROS formation. 
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Neuronal Tissue Oxidative Damage   
Oxidative damage to lipids: As noted earlier, due to its high content in 
PUFAs, brain tissues are very susceptible to LP. A species that can sufficiently 
react to abstract a hydrogen atom from a methylene (–CH2–) group can initiate 
LP. In the case of fatty acids with no or one double carbon-carbon bonds, they 
are more resistant to such attack. However, in the case of PUFAs, the adjacent 
double bonds weaken the energy of the attachment of the hydrogen atoms 
present on the next carbon atom (termed allylic hydrogen), particularly when 
there is a double bond on both sides of the methylene, giving bis-allylic 
hydrogen. As a consequence, the commitment of this carbon to bind with the 
hydrogen atom on it becomes very ambivalent. Therefore, if a free radical comes 
along, it can easily remove the hydrogen atom and the electron associated with 
it. As a result, the free radical is quenched, while the PUFA is turned into a free 
radical, termed alkyl radical (L•). However, LP is a geometrically progressing 
process. The allylic radical can then react with molecular oxygen (O2) and form 
lipid peroxyl radical (LOO•). If this process is not ceased by endogenous 
antioxidant compounds or enzymes, the lipid peroxyl radical will react with other 
PUFAs to form a second allylic radical, while becoming a lipid hydroperoxide 
(LOOH). If there is transition metal ion (Fe2+/Fe3+) comes along, the LOOH 
undergoes decomposition to create an alkoxyl radical (LO•) or a peroxyl racial 
(LOO•). Either lipid radical can attack neighboring fatty acids and thus the 
process of peroxidation propagates throughout the membrane (Figure 1.3). 
 
 15
PUFAs 
 
 
Figure 1.3 Chemistry of initiation and propagation phases of cell membrane LP. 
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As a result, LP decreases membrane fluidity, increases permeability of the 
membrane bilayer to various substances that are normally impermeable and 
inactivates certain membrane-bound enzymes. The continuation of oxidation of 
fatty acid side chains and their fragmentations to produce aldehydic breakdown 
products eventually leads to the loss of membrane integrity. Moreover, the 
products of LP, such as peroxyl radicals, alkoxyl radicals and aldehydes 
(especially 4-hydroxylnonenal) can induce severe damage to proteins. For 
example, 4HNE, an end-product of LP, can conjugate onto proteins causing toxic 
protein aggregates within membranes(Keller, Mark et al. 1997; Kruman, Bruce-
Keller et al. 1997).  
Varieties of superoxide-derived radicals are capable of inducing LP. Acidic 
pH conditions, which is known to occur within severely injured neuronal tissues, 
accelerates superoxide radical to conjugate with H+ to form hydroperoxyl radical 
(HO2•), which is more soluble and much more reactive. As a defense antioxidant 
mechanism, the rate of O2• ⎯ endogenous dismutation into H2O2 is also increased. 
Normally in brain tissues, low molecular weight forms of redox active iron are 
retained, as in other tissues, at extremely low or none levels. Although iron 
storage proteins at neutral pH, such as ferritin and transferrin, have high affinity 
for iron, they are readily to give up iron under acidic conditions. The irons 
released from iron-binding proteins participate in catalyzing LP, in which the most 
studied iron-catalyzed redox reaction is Fenton reaction: 
Fe2+ + H2O2            Fe3+ + •OH + OH⎯ 
   Fe
2+ + H2O2            Fe3+OH + OH⎯ 
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Both •OH and Fe3+ are extraordinary potent oxidants and capable of initiate 
damage to lipids, proteins and DNAs. On the other hand, Haber-Weiss reaction 
may also occur in the presence of transition metals to generate oxidizing 
radicals, though it has a second-order rate constant in aqueous solution of nearly 
zero.  
H2O2 + O2• ⎯              O2 + OH⎯ + •OH  
Fe3+ + O2• ⎯                Fe2+ + O2
   
Fe2+ + H2O2                      Fe3+ + •OH + OH⎯
In addition to iron-dependent radical production, PN-derived •NO2, CO3• ⎯ and 
•OH (Figure 1.2) are potent oxidants that capable of inducing intensive tissue 
damages.  
 Since LP is a complex process with multiple stages, there are many LP 
measurement techniques are available for measuring the rate of peroxidation of 
membrane lipids, lipoproteins or fatty acids. One of the most preferred methods 
is to measure the aldehyde “end-products” of peroxidation, among which 4HNE 
is one of the most cytotoxic aldehydes. Reactive aldehyde, such as 4HNE, binds 
rapidly to proteins, therefore antibody-based immuno-detection of such adducts 
within cells and tissues is considerable. Moreover, immuno-histochemical 
procedure can locate the distribution of such adducts in tissue slices subjected to 
oxidative damage.                                                                                                                         
Oxidative damage to proteins: Damages to proteins can be induced 
directly by ROS, as well as indirectly by end product of LP, such as 
malondialdehyde (MDA) and 4HNE through rapid reaction with thiol (–SH–) 
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groups at physiological pH. Attach of RNS, such as ONOO⎯, •NO2 and NO2Cl, 
leads to 3NT formation. Moreover, •OH or singlet O2 can generate multi end-
products upon proteins. By contrast, H2O2 and O2• ⎯ at physiological level have 
little or no direct effect on proteins. Protein oxidation can lead to specific damage 
to certain amino acid residues. As a result, not only enzymes, but also receptor 
proteins and transport proteins can become a target of oxidative damage.  
The “general” assay of oxidative protein damage is carbonyl assay. The 
rationale is based on the fact that several ROS attack amino acid residues to 
generate products with carbonyl groups, which can be measured after reaction 
with 2,4-dinitrophenylhydrazine (DNPH). The immuno-detection is designed to 
recognize the protein with carbonyl group that is conjugated to DNPH.  
Oxidative damage to DNAs: Oxidative damage to DNAs can lead to strand 
breakage, damage to the deoxyribose sugar and modification of the purine and 
pyrimidine bases. However, nuclease activity occurs during DNA repair can also 
induce strand breakage, but cannot be equated to oxidative DNA damage. The 
most common assay is to measure 8-hydroxydeoxyguanosine (8-OHdG), 8-
hydroxyguanine (8-OH-G) attached to deoxyribose, which is formed by •OH 
attacking upon DNA followed by mono-electron oxidation of the resulting radical. 
  Guanine in DNA                [8-OHdG] 8-OHdG
•OH 
•                         
 – 1e⎯ 
However, the intermediate [8-OHdG]• radical may have alternative fates. 
Therefore, the measurement of a single product of the amount of hydroxylated 
guanine in DNA does not sufficiently indicate the amount of initial radical attack. 
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Moreover, DNA is more susceptible to oxidative damage if it is exposed to H2O2 
(Schraufstatter, Hinshaw et al. 1986).  
  
Mitochondrial Dysfunction in Traumatic Brain Injury 
 
As noted previously, excitotoxicity is a pathological process results in 
neuronal cell death through which the over-activation of receptors for the 
excitatory neurotransmitter, glutamate. N-Methyl-D-aspartate (NMDA) receptors 
are a subclass of glutamate receptors that play an essential role in Na+ and Ca2+ 
influx into the cell (Faden, Demediuk et al. 1989). Na+ gradient cross the plasma 
membrane is required for glutamate uptake. NMDA over-activation will 
exacerbate glutamate accumulation extracellularly and hence Ca2+ influx by 
inducing Ca2+ channels. The unique features of mitochondria allow them to 
accumulate calcium when the intracellular [Ca2+]i reaches a “set-point” of 500nm 
in order to modulate Ca2+ homeostasis in the cytosol (Schinder, Olson et al. 
1996; Nicholls and Ferguson et al. 2002). Mitochondrial dysfunction in regards to 
its Ca2+ buffering capability is an essential mediator of excitotoxicity. Specifically, 
excessive mitochondrial Ca2+ accumulation uncouples electron transfer from ATP 
synthesis leading to mitochondrial dysfunction (Beatrice, Palmer et al. 1980; 
Gunter and Pfeiffer 1990; Bernardi, Broekemeier et al. 1994).  
The disturbance of energy metabolism during Ca2+ overload can result in 
an increase in the mitochondrial leak of oxygen radicals, which can overwhelm 
the antioxidant defense mechanisms and contribute to cell death (Halliwell and 
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Gutteridge et al. 1989; Coyle and Puttfarcken 1993; Lang-Rollin, Rideout et al. 
2003). Oxidants are constantly generated even during normal metabolism as the 
intrinsic rate of proton leakage across the IMM increases, such as O2•⎯, H2O2, 
•OH (Shigenaga, Hagen et al. 1994). There are array of cellular anti-oxidant 
defenses that antagonize the production of oxidants. However, in a variety of 
pathological conditions, such as TBI, the rate of ROS production within 
mitochondria is exacerbated. The main sites for superoxide production are 
suggested to be complex I and complex III of the ETC (Turrens and Boveris 
1980; Sugioka, Nakano et al. 1988). However, the precise nature of the ROS 
production sites in complex I remain obscure. It was also indicated that Ca2+ 
influx induces IMM lipid re-organization by interacting with the anionic head of 
cardiolipin, which is an abundant component in IMM. As a result, mono-electron 
was delivered to oxygen at intermediate steps of respiration, which result in the 
production of O2• ⎯ through ETC (Grijalba, Vercesi et al. 1999). In addition to that, 
NO• production is also detected intramitochondrially through the activation of an 
isoform of NOS located within the mitochondria. It was suggested that this 
isoform of NOS is activated upon Ca2+ uptake (Giulivi 1998; Tatoyan and Giulivi 
1998). Like the three main isoforms of NOS, diversity in its function and location 
gives it a unique role in mitochondria, such as a feedback signal to prevent 
overloading of Ca2+ and decreasing mitochondrial membrane potential (∆Ψm) 
(Ghafourifar and Richter 1997). Although NO• is believed to have potential toxic 
effect, many of them are more likely mediated by PN and its oxidation products 
rather than NO• by itself, such as PN (Bringold, Ghafourifar et al. 2000; Stewart, 
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Sharpe et al. 2000). Evidence showed that the NO•-dependent inactivation of 
iron-sulfur centers was in fact mediated by PN (Castro, Rodriguez et al. 1994; 
Hausladen and Fridovich 1994). Together, mitochondria provide a favorable 
environment for PN-induced oxidative damage in response to Ca2+ uptake.  
Moreover, post-traumatic excessive mitochondrial uptake of Ca2+ can lead 
to a sudden increase in inner membrane permeability to compounds with a 
molecular mass less than 1.5kD, defined as the formation of mitochondrial 
permeability transition pore (mPTP). The mPTP formation is believed to be the 
basis of mitochondrial swelling and metabolic failure and ultimately cell death 
(Zamzami, Hirsch et al. 1997). Although it is considered to be a non-specific 
membrane opening, evidence showed that the onset of the mPTP can be 
prevented by the immunosuppressant cyclosporine A (CsA) suggesting that it is 
more than a non-specific membrane rupture (Bernardi, Broekemeier et al. 1994; 
Bernardi 1996; Nicolli, Basso et al. 1996; Sullivan, Thompson et al. 1999). 
Multiple studies have indicated that the oxidation of mPTP components occurs 
and may play a major role in promoting mPTP formation. It was shown that 
mitochondrial Ca2+ release could be simulated in response to the oxidation of 
mitochondrial pyridine nucleotides, and be inhibited (or reversed) by NAD(P)+ 
reduction (Lehninger, Vercesi et al. 1978). Pro-antioxidants that deplete 
glutathione and promote pyridine nucleotides oxidation also resulted in mPTP 
formation and cell death; whereas diminishing pyridine nucleotide oxidation and 
oxidative stress delayed the onset of mPTP and cell death (Nieminen, Byrne et 
al. 1997). Some evidence has indicated that mPTP occurs when thiol groups of 
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inner membrane proteins are oxidized, which leads to conformational changes. In 
studies on PN-induced protein thiol oxidation, mPTP is paralleled by membrane 
lipid oxidation (Packer and Murphy 1995; Gadelha, Thomson et al. 1997). In 
addition, thiol-specific antioxidants protect against mPTP (Kowaltowski, Netto et 
al. 1998). Other research indicated that the oxidation of adenine nucleotide 
translocator (ANT), an important component of mPTP, through thiol groups 
cross-linking, can facilitate mPTP formation, probably by enhancing cyclophilin 
(CypD) binding, and preventing adenosine diphosphate (ADP) binding (McStay, 
Clarke et al. 2002; Sullivan, Rabchevsky et al. 2004). Skulachev et al 
hypothesized a reason for mPTP would be to ameliorate or eliminate high ROS 
producing cells as a defense system in order to prevent further oxidative damage 
(Skulachev 1996). In this hypothesis, mPTP formation assists maximal O2 
consumption and decreases mitochondrial O2 concentration through dissipating 
membrane potential (∆Ψm) and proton force (∆pH) across the membrane upon 
Ca2+ influx. In other words, it was suggested that elevated mitochondrial ROS 
production plays a regulatory role of oxidative stress to induce “mild” uncoupling 
of mitochondrial respiration and phosphorylation by means of increase in proton 
leak of IMM to promote respiration and ameliorate further ROS production. 
Nevertheless, complete uncoupling of mitochondrial respiration and ADP 
phosphorylation or prolonged uncoupling through mPTP will exhaust ADP in the 
matrix, which increases O2 concentration because of the inhibition of respiration. 
Highly oxidized mPTP will not be able to recover and result in disruption of 
mitochondrial membrane, eventually lead to calcium disturbance as well as 
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release of pro-apoptotic proteins, such as cytochrome c (Cyt c), Smac/DIABLO 
and apoptosis inducing factor (AIF), due to rupture of outer mitochondrial 
membrane (Sullivan, Keller et al. 2002; Halestrap and Brennerb 2003; Green and 
Kroemer 2004; Sullivan, Springer et al. 2004). 
 
Calpain-Mediated Cytoskeletal Proteolysis in Traumatic Brain Injury 
 
Calpain Isoforms: 
 Following TBI, excitotoxicity inducing excessive calcium influx was shown 
to be associated with cell damage. Non-physiological [Ca2+]i rise can exert 
adverse effects by over-activating cellular proteases and lipases (Wrogemann 
and Pena 1976). One of those has been indicated under multiple pathological 
conditions and contributing to cell damage is calpain. Calpains are family of 
calcium-activated cysteinyl/thiol (neutral) proteases, in which cysteine residues 
are present in its active site. The calpain family consists of several tissue-specific 
isoforms (n-calpains) and two ubiquitous isoforms (µ-calpain and m-calpain). 
Calpains are expressed in all vertebrates in which they are highly conserved 
across species. They are also found in various cell types and tissues (Sorimachi, 
Ishiura et al. 1997). The two ubiquitous calpain isoforms are categorized mainly 
on the basis of their sensitivity to [Ca2+] upon activation in their purified state in 
vitro. First of all, µ-calpain (aka. calpain I) has micro-molar sensitivity to calcium 
and is located primarily in the neuronal soma and dendrites. m-Calpain (aka. 
calpain II) has a millimolar sensitivity to calcium activation and is primarily located 
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in axons and glia. Moreover, because of the distinct subcellular localization of the 
calpain subtypes, they may serve specific physiological roles (Hamakubo, 
Kannagi et al. 1986). More interestingly, µ-calpain, which has higher affinity for 
calcium binding, has been shown to located in mitochondria (Garcia, Bondada et 
al. 2005).  
 
Evidence for a Role of Calpain in TBI: 
 Growing interests in calpain due to, in many neurodegenerative diseases, 
etiologic factors such as excitotoxicity, free radical injury and mitochondrial 
homeostasis all lead to disturbance of intracellular Ca2+ level. As one expected 
effect of disruption of Ca2+ homeostasis is the activation of Ca2+-dependent 
lipases and proteases. Among which, calpain family is believed to be very 
important since they proteolysis important enzymes, including protein kinases, 
phosphatases, and modify structure proteins of membrane skeleton (Nixon 
1989). In order to detect calpain activity, protease inhibitors that block calpains 
have been used in experimental TBI models to investigate their activation. These 
inhibitors have been shown to be neuroprotective in vivo as well as in vitro in 
cerebral ischemia (Bartus, Hayward et al. 1994) and TBI models (Saatman, 
Murai et al. 1996; Posmantur, Kampfl et al. 1997; Kupina, Nath et al. 2001; 
Kupina, Detloff et al. 2002). However, due to the uncertain selectivity of these 
inhibitors for calpain proteases, these data have only provided indirect evidence 
for calpain activity after acute CNS injury. Moreover, subunit autolysis seems to 
be an early event in the intramolecular activation of µ-calpain (Saido, Nagao et 
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al. 1992). The ratio of the activated, autolyzed 76kD isoform to the 80kD 
precursor form has been used as an index for µ-calpain activation. Nevertheless, 
others reported that µ-calpain activation does not require autolysis (Edmunds, 
Nagainis et al. 1991). Kampfl et al showed that µ-calpain autolysis was only 
temporally correlated with calpain-mediated α-spectrin breakdown products 
(Kampfl, Posmantur et al. 1996)  
A more commonly used method of measuring calpain activity is to detect 
the presence of breakdown products (BDPs). Preferred substrates for calpain 
include cytoskeletal proteins spectrin, microtubule-associated proteins (MAP2) 
and neurofilament proteins (NF), which are major components of neuronal 
cytoskeleton and membrane (Saatman, Graham et al. 1998). Posmantur et al 
indicated that the occurrence of the loss of neurofilament 68 and low molecular 
weight BDPs associates with TBI (Posmantur, Hayes et al. 1994). Moreover, 
unlike other proteases, such as cathepsins and trypsin, calpain produces 
distinctive breakdown fragments that resemble the patterns observed after TBI. 
More direct evidence of calpain activity is measured by antibody-based immuno-
detection of calpain-mediated α-spectrin breakdown and it is widely used in 
models of TBI (Saatman, Bozyczko-Coyne et al. 1996; Kupina, Detloff et al. 
2002; Hall, Detloff et al. 2004). The α-spectrin breakdown products (SBDPs) are 
produced by both calpain and another cysteine protease, caspase 3. Given that 
the activation of calpain as well as apoptotic enzymes is implicated in different 
neuronal cell death cascades, SBDPs became a useful tool to study both 
proteases in the same model. Calpains are shown to be involved in both necrosis 
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and apoptosis, while caspases are largely involved in apoptosis (Wang 2000). 
Spectrin, as a major constituent of the skeletal network, is a common substrate of 
both calpain and caspase 3, the downstream factor of apoptotic cascade. The 
breakdown of the 280kD protein α-spectrin by either calpain (145kD product) or 
calpain and/or caspase 3 (150kD product) can be detected using antibody-based 
immuno-detection (Wang 2000; Kupina, Detloff et al. 2003; Deng, Thompson et 
al. 2007). The neuronal cytoskeleton is an important component maintaining cell 
architecture, as well as axonal transport, and possibly neuronal plasticity (Ludin 
and Matus 1993). Following experimental acute TBI, evidence has shown 
significant proteolysis of dendritic MAP2 (Taft, Yang et al. 1992). Immuno-
histochemical studies revealed that SBDPs indication of calpain activity occur in 
apical dendrites following TBI (Saatman, Bozyczko-Coyne et al. 1996). 
Moreover, it is shown that NF compaction is associated with proteolysis of NF 
sidearms following traumatic axonal injury (TAI) (Okonkwo, Pettus et al. 1998). 
However, calpain-mediated proteolysis seemed to be involved more with the 
axons that are located in areas with the most severe injury sustained from an 
impact, whereas areas that are with less severity show no calpain-mediated 
change (Saatman, Bozyczko-Coyne et al. 1996). Above all, increasing evidences 
point to the important role of calpain in cytoskeletal de-arrangement and 
degradation, therefore, its possible occurrence in sublethally injured cells. 
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The Relationship of Oxidative Damage, Mitochondrial Dysfunction, Calpain 
Activation and Neurodegeneration in Traumatic Brain Injury 
 
 TBI is one of the leading causes of serious disability and death in children 
and adults. Different severities of TBI from mild, moderate to severe cases can 
all lead to neurological, economical and social burden to not only the patients but 
also the families and the society as a whole (Thurman, Alverson et al. 1999). The 
number of treated cases keeps increasing over the years. To this day, there are 
no clinically proven and FDA approved pharmacological treatments for acute TBI 
patients. Although improved specialized paramedics and emergency treatments 
saved lives on scene that otherwise may die, many patients survived the injury 
continuously suffered from physical, cognitive, emotional and behavioral deficit 
that severely impair their quality of life. It is now understood that most of the 
neurological damage is not the immediate result from the acute mechanical 
impact, but rather an outcome of an evolving pathochemical and 
pathophysiological process following the initial injury over minutes, hours and 
days. However, growing evidences from scientific experiments suggests that 
pharmacological treatments targeting these post-traumatic neurochemical 
changing may lead to a better neurological and behavioral outcome. This 
provides hope in the attempt to not only save lives, but also ensure a better 
quality of life after injury.  
 In order to examine mechanistic hypothesis and to test preclinical 
therapeutics, experimental animal models are essential in scientific investigations 
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(Lighthall, Dixon et al. 1989). In our study, we applied a mouse uni-lateral 
controlled cortical impact (CCI) model of TBI, which is widely used in scientific 
studies. This CCI model yields consistent neurochemical, histological and 
behavioral deficits (Huh, Laurer et al. 2002; Hall, Gibson et al. 2005; Hall, 
Sullivan et al. 2005; Deng, Thompson et al. 2007; Onyszchuk, Al-Hafez et al. 
2007). In this model, a fully anesthetized mouse was placed underneath a 
computer-controlled pneumatic piston. We firstly produced a craniotomy 
positioned between bregma and lambda lateral to sagittal suture. Secondly, the 
pneumatic piston produced a cortical contusion with pre-set parameters. Finally, 
the skin was sutured and the animals were physiologically monitored until regain 
consciousness. The mice recovered well with minimal mortality. Furthermore, this 
model has reproducible gross histological lesions and allows multiple outcome 
measurements. Also, this model can produce different severity of injury that is 
easy to use, affordable and sensitive to intervention.  
 The post-injury secondary cell death cascade is a multi-factorial process. 
Based on the current state of knowledge, three of the most critically important 
pathological elements are ROS formation, mitochondrial dysfunction and 
cytoskeletal degradation. As indicated previously, these injury processes are 
potentially interwoven: primary injury triggered excitotoxicity inevitably induces 
abnormal intracellular Ca2+ increase; consequently, mitochondria as the cellular 
Ca2+ buffer become the primary effecter; meanwhile, mitochondrial NOS and 
Ca2+-dependent proteases are also closely linked to this cellular response, 
leading to possible mitochondrial ROS production and cytoskeletal degradation. 
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Overall, these processes play significant contributory role in the delayed cell 
death. However, the interwoven relationship of these processes makes it difficult 
for therapeutic intervention, and pharmacological interpretation flawed without 
timely assessments.  
The central hypothesis underlying the present study is that an initial 
trauma-induced Ca2+ overload, caused by glutamate and depolarization 
evoked Ca2+ entry, elicits the mitochondrial generation of the ROS species 
PN. PN-derived radical species result in oxidative damage to the 
mitochondria and other cellular elements leading to an exacerbation of 
intracellular Ca2+ accumulation. This in turn exacerbates calpain activity 
which mediates cytoskeletal degradation and neurodegeneration. If this 
scenario is correct, compounds that can penetrate cellular mitochondria 
and antagonize PN-induced oxidative damage (e.g. PN-derived free radicals 
scavenger, tempol) should be neuroprotective in that the resulting 
antioxidant effect will lessen calcium overload, calpain activity and 
associated cytoskeletal degradation and neurodegeneration as shown in 
Figure 1.4. This dissertation study began with a thorough assessment of the time 
course of PN-induced lipid peroxidation and protein nitration, calpain-mediated α-
spectrin breakdown and neurodegeneration with the de Olmos aminocupric silver 
staining method as reported in Chapter 2. Secondly, a detailed pharmacological 
study was conducted using antioxidant, tempol, to determine its ability to inhibit 
post-traumatic oxidative damage. Thereafter, the effect of tempol on 
mitochondrial ROS production and mitochondrial function, as well as calpain 
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activity was tested. These experiments are described in Chapter 3. Finally, the 
ability of tempol to improve neurological outcome and lessen post-traumatic 
neurodegeneration is discussed in Chapter 4. Taken together, these studies 
provide evidence for a post-traumatic pathological scenario that involves a critical 
early role of PN and suggests that interruption of PN-mediated oxidative damage 
is a valid therapeutic strategy. Copyright © Ying Deng 2007.  
 
 
 
Figure 1.4 Hypothetical interrelationship between mitochondrial PN-induced 
oxidative damage in neuronal mitochondria and the rest of the neuron, 
compromise of Ca2+ homeostasis, calpain-mediated proteolysis and 
neurodegeneration.  
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Chapter Two 
Temporal Relationship of Peroxynitrite-Induced Oxidative Damage, 
Calpain-Mediated Cytoskeletal Degradation and Neurodegeneration after 
Traumatic Brain Injury 
 
Introduction 
  
There is compelling evidence supporting the role of oxidative damage in 
the delayed secondary neuronal cell death which is initiated by the primary 
traumatic brain injury (TBI). The first work in this regard, conducted by Kontos 
and his colleagues, demonstrated the formation of  superoxide radicals in 
cerebral microvasculature in a cat fluid percussion TBI models (Kontos and 
Povlishock 1986; Kontos and Wei 1986). Using the salicylate trapping method, 
Hall and coworkers detected a rapid, but transient rise in brain hydroxyl radical 
(•OH) in experimental head injury models (Hall, Andrus et al. 1993; Hall, Andrus 
et al. 1994; Smith, Andrus et al. 1994). This was elegantly confirmed by others 
using brain microdialysis techniques to monitor salicylate-trapped •OH over time 
in the same animals (Globus, Alonso et al. 1995). The increase of •OH is 
followed by an increase in lipid peroxidation products (Smith, Andrus et al. 1994). 
The strongest support for a role of oxidative damage in the acute 
pathophysiology of TBI is derived from the fact that several antioxidant 
compounds have been shown to be neuroprotective in TBI models (Hall, Andrus 
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et al. 1994; Awasthi, Church et al. 1997; Mori, Kawamata et al. 1998; Marklund, 
Lewander et al. 2001).  
The reactive oxygen species (ROS) peroxynitrite (PN), which can produce 
highly reactive and cytotoxic free radicals, has been suggested to be a key player 
in post-traumatic secondary brain oxidative damage (Hall, Kupina et al. 1999; 
Hall, Detloff et al. 2004).  Peroxynitrite is formed by the chemical reaction of nitric 
oxide (NO•), produced by nitric oxide synthase (NOS), with superoxide radical 
(O2• ⎯) whenever the two are produced in close proximity (Saran, Michel et al. 
1990). All three NOS isoforms (eNOS, iNOS, and nNOS), as a key element in 
production of PN, have been shown to be up-regulated in brain tissue following 
TBI (Cobbs, Fenoy et al. 1997; Wada, Chatzipanteli et al. 1998; Gahm, Holmin et 
al. 2000; Orihara, Ikematsu et al. 2001). In addition, a novel isoform of Ca2+-
sensitive NOS (mtNOS), discovered within mitochondria (Bates, Loesch et al. 
1995; Lopez-Figueroa, Caamano et al. 2000; Giulivi 2003), has been shown to 
contribute to mitochondrial production of NO• and PN (Radi, Cassina et al. 2002). 
The PN-derived free radicals (•NO2, •OH, •CO3⎯) can induce extensive oxidative 
damage to cellular membranes, proteins and DNA (Beckman 1996; Murphy, 
Packer et al. 1998; Radi 1998). Each of the PN-derived free radicals can initiate 
lipid peroxidation (LP), or cause protein carbonylation by reaction with 
susceptible amino acids (e.g. lysine, cysteine, arginine). Moreover, aldehydic LP 
products (e.g. 4-hydroxynonenal) can bind to cellular proteins compromising their 
structural and functional integrity (Neely, Sidell et al. 1999). Additionally, •NO2 
can nitrate 3 position of tyrosine residues in proteins. As a result, 3-nitrotyrosine 
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(3NT) is used as a specific footprint of PN-induced cellular damage (Hall, 
Oostveen et al. 1997).  
In recent work we investigated the role of PN in a mouse model of diffuse 
closed head injury which demonstrated the spatial and temporal coincidence of 
PN-induced protein nitration and lipid peroxidation and that this oxidative damage 
precedes, and therefore may have a causal role in post-traumatic 
neurodegeneration (Hall, Detloff et al. 2004). However, TBI is a complex disorder 
that is impossible to fully reproduce in a single model. For example, we have 
found significant differences between the time courses of neurodegeneration in 
mouse models of diffuse (Kupina, Detloff et al. 2003) and focal (Hall, Gibson et 
al. 2005; Hall, Sullivan et al. 2005) TBI. Hence, the magnitude and timing of post-
traumatic secondary injury mechanisms probably varies across head injury 
models. Most importantly, if we are to accurately test the efficacy of novel 
neuroprotective pharmacological treatments, it is important to first understand the 
time course of the relevant secondary injury mechanisms in models of focal as 
well as diffuse TBI.   
Thus, the present study was conducted to examine the temporal and 
spatial characteristics of PN-induced cortical oxidative damage in a model of 
severe controlled cortical impact (CCI) focal TBI, and its relationship to calpain-
mediated cytoskeletal degradation and neurodegeneration. Markers for PN-
induced protein nitration (3-nitrotyrosine, 3NT), and lipid peroxidation (4-
hydroxynonenal, 4HNE) were measured using immuno-slotblotting and immuno-
histochemistry.  Secondly, we employed western-blotting methods to look at the 
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time course of calpain-mediated cytoskeletal degradation in order to assess the 
temporal relationship of oxidative damage to Ca2+-mediated proteolytic 
degradation.  Finally, we used de Olmos silver staining to measure the evolution 
of post-traumatic neurodegeneration. The results demonstrate that the PN-
mediated oxidative damage is an early event that probably contributes to an 
exacerbation of neuronal intracellular Ca2+ overload, massive calpain activation 
and cytoskeletal degradation and neurodegeneration. 
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Materials and Methods 
 
 All the surgical, injury and animal care protocols described below have 
been approved by the University of Kentucky Institutional Animal Care and Use 
Committee, and are consistent with the animal care procedures set forth in the 
guidelines of the U.S. Public Health Service Policy on Humane Care and Use of 
Laboratory Animals. 
 
Mouse Model of Controlled Cortical Impact (Focal) Traumatic Brain Injury 
 Young adult male CF-1 mice (Charles River, Portage, MI) weighing 29-
31g were used in this study. The mice were anesthetized with isoflurane (3.0%), 
shaved, and then placed in a stereotaxic frame (David Kopf Instruments, 
Tujunga, CA). Throughout the surgery, the mice were provided with constant 
isoflurane (SurgiVet, 100 Series) and oxygen (SurgiVet, O2 flowmeter, 0-4Lpm).  
The head was positioned in the horizontal plane of a stereotaxic frame with the 
nose bar set at zero. We firstly produced a 4mm craniotomy lateral to the sagittal 
suture, and centered between lambda and bregma.  A cortical contusion was 
produced on the exposed cortex (the anterior-posterior coordinate for the 
epicenter of the injury was  Bregma -2.0mm) using a pneumatically-controlled 
impactor device (Precision System Instruments TBI-0200 Impactor, Lexington, 
KY) similar to that previously described (Sullivan, Bruce-Keller et al. 1999; 
Sullivan, Thompson et al. 1999; Hall, Sullivan et al. 2005) except that the current 
device utilizes a unique contact sensor mechanism that ensures accurate and 
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reliable determination of cortical surface prior to initiating the injury sequence. 
This results in increased accuracy and reproducibility in regards to the CCI injury 
compared to that produced by earlier CCI impactors.  In the present studies, the 
impactor containing a 3mm diameter rod tip compressed the cortex at 3.5m/sec 
to a depth of 1mm with a dwell time of 50msec to produce a severe injury. After 
surgery and injury, a 4mm disk made from dental cement (Dentsply Trubyte) was 
placed over the craniotomy site and adhered to the skull using cyanoacrylate. In 
order to prevent immediate post-traumatic hypothermia, following the suturing of 
the skin, mice were placed in a Hova-Bator incubator (37˚C, model 1583, Randall 
Burkey Co) until them regained consciousness (determined by the regain of the 
righting reflex and increased mobility). The injured mice were allowed to survive 
from 30 min to 7 days depending on their experimental group. For the 
neurochemical studies (measurement of oxidative damage markers and 
cytoskeletal degradation, see below), the N for each time point group was 8 
animals based upon our experience with the variability seen with these 
measurements in previous studies (Kupina, Detloff et al. 2003; Hall, Detloff et al. 
2004; Hall, Sullivan et al. 2005).  For each time point, two sham animals were 
included which were mice that received craniotomy but not cortical contusion. 
The two sham animals in each group were killed at each of the post-traumatic 
times along with their brain-injured counterparts. Eight sham mice were randomly 
selected for comparison with the injured groups. 
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Tissue Extraction and Protein Assay 
 At the selected times for the time course analysis (30 min, 1 hr, 3 hrs, 6 
hrs, 12 hrs, 24 hrs, 48 hrs, 72 hrs and 7 days), the sham or CCI-injured mice 
were deeply overdosed with sodium pentobarbital (200mg/kg i.p.). Following 
decapitation, the ipsilateral cortex were rapidly dissected on an ice-chilled stage 
and immediately transferred into pre-cooled Triton lysis buffer (1% triton, 20mM 
tris HCL, 150mM NaCl, 5mM EGTA, 10mM EDTA, 10% glycerol) with protease 
inhibitors (Complete MiniTM Protease Inhibitor Cocktail tablet). Samples were 
then briefly sonicated and vortexed at 14,000rpm for 30 min at 4°C, and the 
supernatants were collected for protein assay. Protein concentration was 
determined by Bio-Rad DC Protein Assay, with sample solutions diluted to 
contain 1mg/ml of protein for immunoblotting. 
 
Slot-Immunoblotting Analysis of Oxidative Damage (3NT and 4HNE) 
 To measure 3-nitrotyrosine (3NT) or 4-hydroxynonenal (4HNE), an aliquot 
of each ipsilateral cortical sample (2µg) was diluted with 200µl of tris-buffered 
saline (TBS), and transferred to a Protran (0.2µm) nitrocellulose membrane 
(Schleicher & Schuell, Dassel, Germany) by a Minifold II vacuum slot blot 
apparatus (Schleicher & Schuell). After the samples were loaded into the slots, 
they were allowed to filter through the membrane by gravity (no vacuum). Each 
slot was then washed with 200µl TBS which was allowed to filter through the 
membrane again. The membranes were then disassembled from the apparatus, 
and incubated in a TBS blocking solution with 5% milk for 1 hr at room 
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temperature. For the detection of 3NT, a rabbit polyclonal anti-nitrotyrosine 
antibody (Upstate Biotechnology, MA, USA) was used at a dilution of 1:2000 in 
TBST blocking solution with 5% milk for overnight at 4°C. For the detection of 
HNE, a rabbit polyclonal anti-HNE antibody (Alpha Diagnostics International) was 
used at a dilution of 1:5000 in TBST blocking solution with 5% milk for overnight 
at 4°C. A goat anti-rabbit secondary antibody conjugated to an infrared dye 
(1:5000, IRDye800CW, Rockland) was applied to the membrane for 1 hr at room 
temperature. Dry membranes were then imaged and quantified using the Li-Cor 
Odyssey Infrared Imaging System (Li-Cor® Biosciences). Preliminary 
experiments established protein concentration curves in order to ensure that 
quantified blots were in the linear range. From the results of these, we selected 
the 2µg for use based upon that amount giving blots that were well within the 
linear range. A standardized protein loading control was included on each blot to 
normalize the band densities so that comparisons could be made across multiple 
blots. All the samples were run in duplicate which were then averaged. For both 
the 4HNE and 3NT analyses, no primary antibody controls were run to verify that 
the oxidative damage staining was specific. In addition, we ran positive controls 
using both bovine serum albumin and normal brain tissue which were exposed to 
PN and negative controls in which we pre-absorbed the primary antibodies with 
either 4HNE or 3NT which resulted in inhibition of the 4HNE and 3NT staining.   
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Immunohistochemical Analysis of Oxidative Damage (3NT and 4HNE) 
A second set of animals was employed for immunohistochemical analysis 
of 3NT and 4HNE. At the appointed times for the post-traumatic time course 
analysis (30 min, 1 hr, 3 hrs, 6 hrs, 12 hrs), groups of 5 mice each were 
overdosed with sodium pentobarbital (200mg/kg i.p.). Two sham, non-injured 
mice that had craniotomies, but no injury, were included for each time point. The 
mice were then perfused transcardially with 0.9% sodium chloride (pH7.4) until 
the venous effluent (sectioned superior vena cava) was cleared of blood,  
followed by a fixative solution made with 4% paraformaldehyde in 0.2M PBS 
(pH7.4). The heads were decapitated after fixation and stored in the same 
fixative solution overnight at 4°C. The brains were removed and equilibrated in 
the same fixative solution with 15% sucrose overnight at 4°C. The equilibrated 
brains were sectioned at a thickness of 35µm into the same fixative solution with 
15% sucrose at -20°C using a microtome with a freezing stage.  
For the 4HNE detection, the free-floating sections were pre-treated with 
0.1M NaBH4 in 0.1M MOPS (pH8.0) for 10 min and rinsed off with 0.2M PBS for 
three times. The sections were then incubated in 0.3% H2O2 for 30 min and 
rinsed three times with 0.2M phosphate-buffered saline (PBS). Following that, the 
sections were blocked with a blocking solution (5% goat serum, 0.25% Triton X-
100, 1% dry milk, 0.2M PBS) for 2 hrs at room temperature, and then incubated 
in the primary anti-HNE antibody (rabbit anti-HNE Michael Adducts, Calbiochem) 
diluted 1:5500 in the same blocking solution overnight at room temperature. The 
sections were then rinsed with 0.2M PBS six times, and then incubated in 
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secondary goat anti-rabbit antibody (Vectastain ABC-AP kit) for 2 hrs at room 
temperature. The sections were then rinsed with 0.1M Tris-HCl (pH8.2) and 
incubated in Vector blue (Vector blue alkaline phosphatase substrate kit III). They 
were then rinsed with tap water four times, and mounted onto gelatinized slides. 
For the 3NT detection, the sections were not pre-treated with 0.1M NaBH4 in 
0.1M MOPS (pH8.0), but were treated the same for the rest of the procedure, 
except that they were incubated in the primary anti-3NT antibody (rabbit anti-
nitrotyrosine, Upstate) diluted 1:1200 in the blocking solution. For both the 4HNE 
and 3NT analyses, control slides were run without the primary antibodies to verify 
that the oxidative damage staining was specific. In addition, we ran additional 
controls in which we pre-absorbed the primary antibodies with either 4HNE or 
3NT which resulted in inhibition of the 4HNE and 3NT immunostaining.  After the 
immunohistochemical procedure, all slides mounted with brain sections were 
counterstained with nuclear fast red (Vector Lot# Q1214), and then cover 
slipped. The brain sections were photographed on an Olympus Provis A70 
microscope at 1.25x, 20× and 40× magnification using an Olympus Magnafire 
digital camera. 
 
Western-blotting Analysis of Calpain-mediated Cytoskeletal Degradation 
 To measure calpain-mediated α-spectrin proteolysis, aliquots of each 
cortical sample (5µg) were run on a SDS/PAGE Precast gel (3-8% Tris-Acetate 
CriterionTM XT Precast gel, Bio-Rad) and then transferred to a nitrocellulose 
membrane using a semi-dry electro-transferring unit set at 15V for 15 min. 
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Preliminary experiments established protein concentration curves in order to 
ensure that quantified bands were in the linear range as measured with the Li-
Cor Odyssey Infrared Imaging System.  The membranes were incubated in a 
TBS blocking solution with 5% milk for 1 hr at room temperature. For the 
detection of α-spectrin and its breakdown products, a mouse monoclonal anti-α-
spectrin antibody (Affiniti FG6090) was used at a dilution of 1:5000 in TBST 
blocking solution with 5% milk for overnight at 4°C. A goat anti-mouse secondary 
conjugated to an infrared dye (1:5000, IRDye800CW, Rockland) was then 
applied for 1 hr at room temperature. After drying, the membranes were then 
imaged and quantified using the Li-Cor Odyssey Infrared Imaging System. A 
standardized protein loading control was included on each blot to normalize the 
band densities so that comparisons could be made across multiple blots (Hall, 
Sullivan et al. 2005). This was made up of pooled brain tissue protein collected 
from previously run TBI mice which gave strong bands corresponding to the 
280kD parent α-spectrin, the 150kD and the 145kD breakdown products.  The 
amount of protein in the loading control had been previously determined and 
shown to be within the linear range as measured with the Li-Cor Odyssey 
Infrared Imaging System.  Following the transfer, the gels were stained with 
Coomassie Blue to verify even transfer. All the samples were run in duplicate and 
averaged. 
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De Olmos Silver Staining Analysis of Neurodegeneration 
 Neurodegeneration was examined using the de Olmos aminocupric silver 
histochemical technique in a third set of 27 mice as previously described (de 
Olmos, Beltramino et al. 1994; Switzer 2000; Hall, Gibson et al. 2005; Hall, 
Sullivan et al. 2005).  At either 6, 12, 24, 48, or 72 hrs or 7 days the injured mice 
(N=3-4 per time point) were overdosed with sodium pentobarbital (200mg/kg i.p) 
and transcardially perfused with 0.9% sodium chloride, followed by a fixative 
solution containing 4% paraformaldehyde; a sham group of 4 mice that received 
craniotomy only were sacrificed 24 hrs following surgery.  Following decapitation, 
the heads were stored in a fixative solution containing 15% sucrose for 24 hrs 
after which the brains were removed, placed in fresh fixative and shipped for 
histological processing to Neuroscience Associates Inc (Knoxville TN).  The 27 
brains used for this study were embedded into one gelatin block (Multiblock® 
Technology, Neuroscience Associates). The block was then frozen and thirteen 
35µm coronal sections were taken 420µm apart between 1.1mm anterior and 
4.4mm posterior to bregma, were de Olmos silver-stained to reveal degenerating 
neurons and neuronal processes, and then counterstained with Nuclear Fast 
Red. The brain sections were photographed on an Olympus Provis A70 
microscope at 1.25× magnification using an Olympus Magnafire digital camera 
and the image was analyzed by Image-Pro Plus (4.0). The percentage area of 
silver staining for each brain section was calculated by dividing the area of silver 
staining in each section by the area of the total hemispheric section and 
multiplying by 100. The volume of silver staining in the hemisphere as a 
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percentage of the overall hemispheric volume was estimated by the equation % 
V = t × Σ % a(s), where % V is percent silver stain volume, t = the distance 
between sections analyzed (420µm) and Σ % a (s) is the sum of percent area of 
silver staining in all sections examined (13 for each brain) (Hall, Sullivan et al. 
2005). 
 
Statistical Analysis 
 For all of the time course analyses, we used Statview 5.0 to perform a 
one-way analysis of variance (ANOVA), followed by Fisher’s PLSD post-hoc 
analysis to determine the significance of differences between individual time 
points and the non-injured sham group. For the ANOVA, a p<0.05 was required 
to establish a statistically significant difference across the groups. However, for 
the post-hoc Fisher’s analysis, the program determined significance based upon 
a correction for multiple comparisons comparing sham to each of the 9 post-
injury time points. Differences between pairs of post-injury time points (e.g. 30 
min. vs. 1 hr) were also analyzed. 
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Results 
 
Quantitative Post-Traumatic Time Course of Protein Nitration and Lipid 
Peroxidation 
Figure 2.1 displays the complete quantitative time course study for 3NT 
and 4HNE in the ipsilateral cortical samples taken from sham or CCI-injured 
mice. Figure 2.1A indicates schematically the dorsal and coronal view of 
contusion site and peri-contusional cortical tissue that was collectively sampled 
for the current study. Figure 2.1B shows the time course of changes in 3NT, a 
selective marker of PN-mediated damage. As noted in the MATERIALS AND 
METHODS, two non-injured sham animals corresponding to each post-traumatic 
time point were run. For the nine time points, this resulted in a total of 18 shams.  
A comparison of the bands obtained from different pairs of shams, showed little 
evidence that those animals killed at the later time points had any more 3NT or 
4HNE than those sampled at the earlier time points.  Therefore, we randomly 
selected 8 of the 18 shams to use as the sham group for comparison with the 
different injured groups. The ANOVA showed that there was a highly significant 
overall difference across the collective sham and post-traumatic groups in 
regards to 3NT levels [F(9,70)=2.744; p<0.0001]. Post-hoc analysis revealed a 
significant increase in 3NT at 30 min after injury compared to the sham group. At 
1 hr after injury, the 3NT level reached its peak and was approximately twice as 
much as that seen in sham, non-injured mice. The 3NT level maintained 
significantly high until 12 hrs after injury, and at 24 hrs, it returned to baseline 
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(sham level).  However, a small, but statistically significant secondary increase in 
3NT was also observed at 48, but not at 72 hrs.   
Figure 2.1C displays the time course of post-traumatic changes in 4HNE, 
a marker for lipid peroxidation, at different time points after injury. As with the 
3NT analysis, there was a highly significant overall difference across the 
collective sham and post-traumatic groups in regards to 4HNE content 
[F(9,70)=15.211; p<0.0001]. Post-hoc analysis of between group differences 
showed that there was a significant increase in 4HNE at 30 min after injury, the 
4HNE level reached its peak at 1 hr after injury and it stayed significantly higher 
than the sham level until 12hr before returning to the baseline levels seen in the 
sham animals.  
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Figure 2.1 Slot-blotting studies in ipsilateral cortical traumatic brain injury tissues 
showing the temporal changes in protein nitration (3-nitrotyrosine; 3NT) and lipid 
peroxidation. A. Schematic showing peri-contusional cortical tissue samples; B. 
time course of changes in 3-NT; C. Time course of LP end product 4HNE. N = 8 
animals per timepoint; values = mean + standard error; one-way ANOVA and 
Fisher’s PLSD post hoc test: *P < 0.0001 vs. sham. 
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Spatial and Temporal Distribution of Peroxynitrite-Induced Protein Nitration and 
Lipid Peroxidation 
Figure 2.2 demonstrates the temporal and spatial characteristics of the 
immunohistochemical staining related to post-traumatic oxidative damage in the 
ipsilateral hemisphere of mice after CCI injury. Two adjacent brain sections in the 
epicenter (Bregma-2.0mm) of the contusion were selected for 3NT staining and 
4HNE staining.  In Figure 2.2, the staining for 3NT and 4HNE markers were 
concentrated within and around the contusion area in the ipsilateral cortex, and 
the 3NT and 4HNE staining was largely overlapping. Staining for both markers 
was observed as early as 30 min.  Staining remained intense up to 6 hrs after 
injury. At 12 hrs, the staining showed signs of decrease no doubt due to 
proteolytic degradation of the oxidatively modified proteins. This time course is in 
good agreement with the quantitative time course for 3NT and 4HNE shown in 
Figure 2.1.   
Figure 2.3 shows high power photomicrographs of 3NT and 4HNE 
immunostaining within the cortical contusion site in a sham, non-injured brain 
compared to staining at the contusion site at 1 hr after injury.  At 20x and 40x 
magnification, intense staining for both oxidative damage markers is seen 
throughout the neuropil. In addition, microvascular staining for both 3NT and 
4HNE is seen to clearly outline the microvessels deep within the injured cortex.  
Although the sham brain shows some light staining in the neuropil, there is no 
evidence of staining of non-injured microvessels.  The pattern of staining in both 
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the parenchyma and vasculature has also been seen previously after a diffuse 
brain injury (Hall, Detloff et al. 2004). 
 
 
Figure 2.2 Immunohistochemical (IHC) staining studies showing the time course 
and spatial extent of PN-induced 3NT and 4HNE at the epicenter (Bregma-
2.0mm) of the injury site during the first 12 hrs compared to sham. The IHC 
staining indicated prominent increase of both markers after injury and similar 
distribution between the two. 
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Figure 2.3 High power photomicrographs of 3NT and 4HNE immunostaining in 
the contusion site in a sham, non-injured brain compared to staining at the 
contusion site at 1 hr after injury.  At 20x and 40x magnification, intense staining 
for both oxidative damage markers is seen throughout the neuropil.  In addition, 
microvascular staining for both 3NT and 4HNE is seen to clearly outline the 
microvessels (arrows) deep within the injured cortex.  Although the sham brain 
shows some light staining in the neuropil, there is no evidence of staining of non-
injured microvessels.  Please note that the 20x and 40x focus was adjusted to 
emphasize the microvascular staining, and as a result the background tissue 
appears slightly out of focus.  The calibration bar for the 1.25x photomicrographs 
is 2.0mm; for 20x the calibration bar is 100µm; for 40x the calibration bar is 
50µm. 
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Quantitative Post-traumatic Time Course of Calpain-Mediated Cytoskeletal 
Degradation  
Figure 2.4 displays the quantitative post-traumatic time course analysis of 
calpain-mediated cytoskeletal degradation in the ipsilateral cortical tissue in 
terms of the levels of α-spectrin breakdown products SBDP145 and 150 
measured by western-blotting. The spectrin breakdown product 145 (kD) and 150 
(kD) in each time group were compared to the sham SBDP145 and the sham 
SBDP150 respectively. The SBDP150 band can be produced by either calpain or 
caspase 3, whereas the SBDP145 band is calpain specific. ANOVA showed that 
there was a significant overall post-traumatic increase in SBDP145 
[F(9,70)=9.444; p<0.0001] and SBDP150 [F(9,70)=8.857; p<0.0001]. 
Accordingly, post-hoc analysis of the significance of increases seen at individual 
post-traumatic time points was compared to sham, non-injured animals. At 30 
min after injury, the mean SBDP150 level was significantly increased. The levels 
of this mixed calpain/caspase 3 marker remained significantly higher than sham 
levels at all subsequent time points out to, and including, 48 hrs post-injury. The 
maximum increase in SBDP150 was observed at 24 hrs post-injury. The calpain-
specific SBDP145 showed a significant increase vs. sham beginning at 1 hr post-
injury, and increased slightly more at 3, 6 and 12 hrs.   
Between 12 and 24hrs, there was a statistically significant (12 hr vs. 24 hr; 
p<0.0004) 75% jump in SBDP145 levels with the 24 hrs time point manifesting 
the maximum post-traumatic increase. In parallel, there was an equally 
significant (12 vs. 24 hr; p<0.0001) increase in the SBDP150 levels SBDP150.  
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The magnitude of the increase in SBDP145 was greater (compared to the sham 
group) (18-fold) in comparison to the SBDP150 increase (6-fold).  The level of 
SBDP145 remained significantly elevated at 48 hrs before returning to levels at 
72 hrs after TBI that were no longer significantly higher than those seen in sham 
animals. The overall time course patterns were similar for both SBDP150 and 
SBDP145.   
It should be noted that the current post-traumatic time course of α-spectrin 
degradation, although similar in several respects to a time course study we 
published earlier (Hall, Sullivan et al. 2005) using the CCI model, shows some 
differences that are worthy of explanation.  In the previous study, the earliest 
post-traumatic time point examined was 6 hrs at which time we observed a 
statistically significant increase in SBDP145 and 150 compared to sham, just as 
in the present study.  However, the elevation in SBDPs did not increase further at 
24 or 48 hrs, but rather appeared to plateau before returning to the sham 
baseline level at 1 week.  This is in contrast to the significantly higher peak in 
SBDP 145 and 150 observed in the current study.  There are two likely reasons 
for the discrepancy between the current and the previously published time course 
(Hall, Sullivan et al. 2005).  First of all, in the current study we employed a more 
sensitive infrared imaging method for performing the densitometric analysis of 
the blots which has a broader linear range compared to the less sensitive 
enhanced chemiluminescence (ECL) method that we previously employed which 
is only semi-quantitative. Consequently, the previous plateau between 6 and 72 
hrs post-injury (Hall, Sullivan et al. 2005), in contrast to the current results is 
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probably due to the less accurate nature of ECL vs. infrared imaging.  Secondly, 
the current study was performed with a newer CCI device than the one used in 
the previous study.  The newer device (PSI TBI 0200 Impactor) utilizes a unique 
contact sensor mechanism that insures accurate and reliable determination of 
cortical surface prior to initiating the injury sequence. This results in increased 
accuracy and reproducibility in regards to the CCI injury.  Thus, for these two 
reasons, we have more confidence in the accuracy of the current results in 
regards to the time course of post-traumatic cytoskeletal degradation. 
Furthermore, the current time course of α-spectrin degradation in the CCI-injured 
cortex is similar in pattern to the time course of α-spectrin degradation we have 
seen in the injured hippocampus using the same injury device, injury severity and 
infrared imaging of the blots (Thompson, Gibson et al. 2006)  
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Figure 2.4 Time course of the post-traumatic increase in calpain-mediated α-
spectrin breakdown products in CCI cortical tissues. Spectrin breakdown product 
(SBDP) 145 is specific to calpain activity, whereas SBDP 150 is produced by 
both calpain and caspase 3. Both SBDPs showed similar patterns, except that 
calpain-mediated SBDP 145 showed a more prominent increase. Both SBDPs 
have an immediate increase following injury, and did not reach their peak until 24 
hrs. N = 8 animals per timepoint; values = mean + standard error; one-way 
ANOVA and Fisher’s PLSD post hoc test: *P < 0.0001 vs. sham SBDP150; one-
way ANOVA and Fisher’s PLSD post hoc test: #P < 0.0001 vs. sham SBDP145. 
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Quantitative Post-Traumatic Time Course of Neurodegeneration 
Figure 2.5 shows the quantitative de Olmos aminocupric silver staining 
analysis of neurodegeneration in the ipsilateral hemisphere of mice subjected to 
CCI along with histological examples of the spatial and temporal characteristics 
of silver staining between 6 hrs and 7 days after injury. At 6 hrs after injury, there 
was a significant increase of silver staining volume compared to minimal level 
seen in sham, non-injured mouse brains. The silver staining spread over time 
and peaked at 48 hrs after injury. After 48 hrs, the volume of silver staining slowly 
waned, but remained significantly higher than the sham level even at 7 days. As 
shown in the selected brain sections, at 6 hrs, the silver staining was mainly 
concentrated in all layers in the ipsilateral cortical contusion. A cavitation lesion 
began to develop at 12 hrs and became evident at 24 hrs. At 24 hrs, the silver 
staining had spread into and throughout the ipsilateral hippocampus and 
dorsolateral aspect of the thalamus. At 48 hrs, the silver staining volume reached 
its greatest extent. Silver staining also extended to the contralateral 
hippocampus, indicative of the degeneration of CA3 commissural fiber 
projections to the contralateral dentate gyrus and CA1 region as previously 
shown (Hall, Sullivan et al. 2005).  
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Figure 2.5 Time course of post-traumatic neurodegeneration in CCI model as 
revealed by the de Olmos silver staining technique. The bar chart provides the 
quantification of the lesion volume abut measurement of the silver staining. An 
increase in silver staining volume determined by image analysis (see Materials 
and Methods) occurred as early as 6 hrs and reached its peak at 48 hrs post-
injury. N = 3-4 animals per time point; values = mean + standard error; one-way 
ANOVA and Fisher’s PLSD post hoc test: *P < 0.0001 vs. sham. 
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Discussion 
 
The present study in the context of the focal controlled cortical impact 
(CCI) mouse model has uniquely defined in a parallel fashion the time courses of 
oxidative damage, calpain-mediated cytoskeletal degradation and 
neurodegeneration. A careful analysis of these three secondary injury 
parameters has revealed clues concerning their mechanistic inter-relationships. 
The following discussion lays out the hypothesis that 1) the potent ROS PN is a 
key mediator of post-traumatic oxidative damage; 2) a major source of PN is 
Ca2+-overloaded mitochondria; 3) a major consequence of PN-mediated oxidative 
damage is exacerbation of intracellular Ca2+ overload by impairment of Ca2+ 
homeostatic mechanisms and 4) this leads to an enhancement of calpain-
mediated cytoskeletal degradation which is the immediate precursor of post-
traumatic neuronal degeneration.  
 
Temporal and Spatial Characteristics of Oxidative Damage and the Role of 
Peroxynitrite:  
The two oxidative markers: tyrosine nitration (3NT) and LP-derived 4HNE 
modified proteins (see Halliwell and Gutteridge, 1999), increased in unison. Their 
increase occurred as early as 30 min after injury and peaked at 1hr. The 
coincidence of the early time course of 3NT and 4HNE suggests that they share 
a common ROS as their initiating source. The most likely candidate ROS in this 
regard is PN.  The nitration of the 3 position of tyrosine residues in proteins is a 
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result of PN activity and is used as a selective marker for PN-induced oxidative 
damage. Therefore, it is generally accepted as evidence of a role of PN in tissue 
injury models where 3NT elevations are seen (Beckman 1996). Moreover, the 
indictment of PN as a source of LP (4HNE) is strongly implied by the fact that 
3NT and 4HNE share the same early post-traumatic onset (30 min), time to peak 
(1 hr) and duration (12 hrs). Furthermore, spatial overlap of 3NT and 4HNE seen 
in the immunohistochemical examples also indicates that nitration and LP are 
both initiated by PN. Previous work from our laboratory using a mouse model of 
diffuse TBI, has also shown the spatial and temporal coincidence of 3NT and 
4HNE immunostaining leading to a similar conclusion that PN was  key player in 
the post-traumatic oxidative damage (Hall, Detloff et al. 2004).  However, in the 
case of the previously studied diffuse TBI model, the duration of the increase in 
3NT and 4HNE was much longer (at least 96 hrs) in contrast to the much shorter 
expression of oxidative damage in the presently employed focal paradigm.  
Particularly important is the fact that PN-mediated oxidative damage was 
observed in both the cortical microvessels and in the neural parenchyma 
consistent with our earlier studies in the mouse diffuse TBI model (Hall, Kupina et 
al. 1999; Hall, Detloff et al. 2004) 
 
Sources of Peroxynitrite: 
Regarding the sources of PN in the injured brain, NO• is produced by 
multiple NOS isoforms, and is a mediator of physiological (Garthwaite and 
Boulton 1995; Bicker 2001) and neuroprotective (Mohanakumar, Hanbauer et al. 
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1998; Chiueh 1999) actions as well as being an effecter of PN formation and 
oxidative damage (Dawson and Dawson 1996; Vicente, Perez-Rodriguez et al. 
2006). An earlier immunocytochemical study revealed the induction of endothelial 
NOS (eNOS) isoform in microvessels surrounding the cortical contusion post-
injury, which may contribute to blood-brain barrier (BBB) breakdown and 
hyperemia followed by TBI (Cobbs, Fenoy et al. 1997).  Other isoforms of NOS, 
neuronal NOS (nNOS) and inducible NOS (iNOS), have also been shown to be 
upregulated in TBI models. In a focal brain contusion model, all three isoforms of 
NOS (nNOS, eNOS, iNOS) have been found to be increased. However, each is 
expressed in different compartments and cells, and is differentially regulated 
(Gahm, Holmin et al. 2000). In addition, a possibly novel isoform of NOS 
(mtNOS) is constitutively present in mitochondria, is Ca2+-dependent (Giulivi 
2003) and appears to be involved in mitochondrial respiratory regulation 
(Elfering, Sarkela et al. 2002).  Under hypoxic conditions, mtNOS activity is 
induced in comparison to that seen in non-stressed mitochondria (Lacza, Puskar 
et al. 2001).  In rat liver mitochondria, mtNOS has been shown to stimulated by 
Ca2+ influx (Ghafourifar and Richter 1997) and leads to intramitochondrial PN 
formation (Ghafourifar, Schenk et al. 1999). Furthermore, there is evidence that 
mitochondria may be the primary target for oxidative damage by PN under a 
variety of pathological conditions (Radi, Rodriguez et al. 1994). Consistent with 
this view, recent experiments from our laboratory, using the same mouse CCI 
model as in the present study, have shown that the early post-traumatic 
impairment of mitochondrial ultrastructure and bioenergetics are associated with 
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PN-mediated protein nitration and 4HNE conjugation together with a severe 
attenuation of Ca2+ buffering capacity (Singh, Sullivan et al. 2006a). Furthermore, 
our in vitro studies with isolated brain mitochondria have demonstrated that 
application of compounds such as penicillamine, which scavenges PN anion 
(ONOO•) and peroxynitrous acid (ONOOH) (Hall, Kupina et al. 1999), or tempol, 
which catalytically scavenge PN-derived oxygen radicals (e.g. •NO2, •CO3) 
(Carroll, Galatsis et al. 2000), can protect against PN-mediated mitochondrial 
respiratory dysfunction and oxidative damage (Singh et al, 2006b). Both 
penicillamine (Hall, Kupina et al. 1999) and tempol (Beit-Yannai, Zhang et al. 
1996) have been reported to improve neurological recovery in rodent TBI 
models. Moreover, administration of the NOS inhibitors nitro-arginine methyl 
ester and 7-nitroindazole have been shown to improve neurological recovery in 
head-injured mice (Mesenge, Verrecchia et al. 1996) together with a reduction in 
brain 3NT levels (Mesenge, Charriaut-Marlangue et al. 1998).  
 
Temporal Characteristics of Calpain-Mediated Cytoskeletal Damage:  
Several experimental TBI studies from different laboratories have 
documented the significant contribution of calpain activity to the post-traumatic 
damage and neurodegeneration (Arrigoni and Cohadon 1991; Posmantur, 
Kampfl et al. 1996; Saatman, Murai et al. 1996). Pathological calpain activation is 
known to be triggered by excessive intracellular Ca2+ accumulation (Bartus, Elliott 
et al. 1995; Kampfl, Posmantur et al. 1997), which is associated with the 
glutamate release and sustained NMDA activation, as well as depolarization-
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induced opening of voltage-dependent Ca2+ channels immediately after CNS 
trauma. Preferred substrates for calpain include cytoskeletal proteins, 
membrane-associated proteins, signaling transduction proteins and transcription 
factors (Carafoli and Molinari 1998; Wang 2000). As noted earlier, calpain-
mediated proteolysis of the major membrane cytoskeletal protein, α-spectrin, 
results in the appearance of two highly stable breakdown products, calpain-
specific SBDP145 and the non-specific calpain/caspase 3-generated SBDP150. 
Our results showed that there is a rapid accumulation of both SBDPs by 1 hr 
after injury which further increases at 3 hrs before reaching a plateau at 6 and 12 
hrs. Nevertheless, at 24 hrs, both SBDPs showed a significant increase above 
the level seen at 12 hrs spiked to their peak with a particularly prominent 
SBDP145 increase.  Although a role of caspase 3 cannot be ruled out in regards 
to the increase in SBDP150, the predominant elevation in the calpain-specific 
SBDP145 at 24 hrs indicates that the major contribution of calpain to cytoskeletal 
damage. In addition, the caspase 3 specific SBDP120 (Wang 2000) showed no 
increase over time which suggests only a very minor role of caspase 3 in post-
traumatic spectrin proteolysis. After 24 hrs, the SBDP 145 and 150 levels 
progressively subsided, and both returned to the baseline level (sham) by 72 hrs 
after injury. 
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Interaction of Peroxynitrite-Induced Oxidative and Calpain-Mediated Proteolytic 
Damage Mechanisms:  
Multiple lines of evidence have linked ROS-initiated oxidative damage to 
the loss of intracellular Ca2+ homeostasis and calpain activation. It has been 
commonly indicated that ROS cause a rapid increase in cytoplasmic Ca2+ 
concentration in diverse cell types (Roveri, Coassin et al. 1992; Chakraborti, Das 
et al. 1999; Okabe, Tsujimoto et al. 2000), which can contribute to the early 
transient calpain activation. However, the current study indicated that the full 
activity of calpain did not occur until a later time point that follows the early wave 
of oxidative damage and the peak of   mitochondrial dysfunction (Singh, Sullivan 
et al. 2006a). At the point at which mitochondrial functional failure occurs, this 
results in a loss of mitochondrial Ca2+ buffering and release of accumulated Ca2+ 
into the cytoplasm which would be expected to exacerbate calpain activation and 
spectrin breakdown. It has been shown that mitochondria-derived PN plays a role 
in mitochondrial Ca2+ overload, and can actually promote Ca2+ release from intact 
mitochondria (Bringold, Ghafourifar et al. 2000). Moreover, we have previously 
demonstrated that the mitochondrial failure is coincident with oxidative damage 
to mitochondrial proteins and loss of mitochondrial Ca2+ buffering capacity 
(Singh, Sullivan et al. 2006a). In an in vitro study, nitric oxide-elicited neuronal 
apoptosis through excitotoxicity and receptor-mediated intracellular Ca2+ 
overload mechanisms was blocked by calpain inhibitors (Volbracht, Chua et al. 
2005). Another in vitro study has also indicated that PN-initiated cell death in 
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human articular chondrocytes is mediated by mitochondrial dysfunction and 
calpain activity (Whiteman, Armstrong et al. 2004).  
In addition to the apparent role of ROS in the post-traumatic impairment of 
Ca2+ homeostasis, ROS also are involved in directly regulating calpain proteolytic 
activity. As indicated in Figure 2.4, following an immediate and rapid increase of 
SBDPs at 1 hr after injury, there is essentially a plateau in regards to the SBDP 
levels between 3 hrs and 12 hrs.  Then, between 12 hrs and 24 hrs, both SBDPs 
exhibited a greater than 75% increase which was highly significant (p<0.0004 for 
SBDP145 and p<0.0001 for SBDP150). A similar biphasic pattern of calpain-
mediated α-spectrin degradation has also been observed by our laboratory in the 
context of a rat spinal cord injury model (Xiong, Rabchevsky et al. 2007) and by 
others in a transient ischemic brain injury model (Neumar, Meng et al. 2001). In a 
recent hippocampal organotypic slice study, stretch-induced injury also showed a 
biphasic activation of calpain (DeRidder, Simon et al. 2006). This repeatedly 
demonstrated biphasic time course of calpain-mediated proteolysis can 
potentially be explained by an initial partial ROS-mediated inhibition of calpain 
activity in the early post-traumatic hrs during which PN generation and evidence 
of oxidative damage are at their highest level. Consistent with this hypothesis, it 
has been shown that ROS can inhibit calpain activity via oxidation of the 
sulfhydryl groups of cysteine residues at the active site of the enzyme (Benuck, 
Banay-Schwartz et al. 1992; Guttmann, Elce et al. 1997; Guttmann and Johnson 
1998). Recent work by another group has shown that another cysteine protease 
caspase 3 in the traumatized brain is similarly inhibited by PN specifically, and 
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that this is prevented by application of the sulfhydryl reducing agent dithiothreitol 
(Lau, Arundine et al. 2006).  The latter is also relevant since the SBDP150 
fragment which also showed a biphasic time course is partially generated by 
caspase 3 as well as calpain (Wang 2000). Therefore, it is reasonable to 
speculate that even though intracellular Ca2+ overload is triggered immediately 
after injury (Zhou, Xiang et al. 2001), the peak of calpain- and caspase-mediated 
cytoskeletal degradation may not be achieved until as much as 24 hrs post-injury 
after which an initial ROS-mediated calpain and caspase inhibition has subsided. 
In other words, as the intensity of the PN generation decreases, the oxidative 
damage-mediated impairment of various Ca2+ homeostatic mechanisms and the 
neurodegenerative consequences of post-traumatic intracellular Ca2+ overload 
and peak calpain activity would have the opportunity to be fully seen. This peak 
in calpain-mediated damage at 24 hrs closely precedes the progressive increase 
in post-traumatic neurodegeneration (silver staining) which peaks at 48 hrs.   
We have observed the same close association between calpain-mediated 
cytoskeletal degradation and neurodegeneration in the mouse diffuse TBI model 
except that the peak of the former is seen at 72 hrs and that of the latter is seen 
between 72 and 96 hrs (Hall, Detloff et al. 2004).  The different time course of 
PN-mediated oxidative damage and calpain-mediated cytoskeletal degradation 
seen in focal and diffuse (Kupina, Detloff et al. 2003) TBI models suggests that 
the therapeutic window and optimum treatment durations for either PN-directed 
antioxidant agents or calpain inhibitor treatment may differ between the two types 
of TBI.   
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Summary: 
Our working hypothesis, based upon the findings in this study, is 
illustrated in Figure 2.6. Initial mechanical trauma to the brain causes membrane 
depolarization, resulting in the opening the voltage-dependent Na+, K+ and Ca2+ 
channels, and the release of glutamate into the extracellular spaces, which will 
lead to the activation of NMDA receptors. Both mechanisms directly or indirectly 
elevate intracellular Ca2+ and rapidly initiate the activation of intracellular 
calpains. However, mitochondria take up the excessive Ca2+ in the cell, which 
subsequently activates mitochondrial NOS and results in overproduction of NO• 
radical. Elevated NO• out-competes superoxide dismutase (SOD) for superoxide 
radical (O2• ⎯) leading to the formation of PN. Then, PN-derived free radicals 
could be expected to initially produce a partial inhibition of calpain and caspase 3 
activity. Mitochondria, however, as a major intracellular ROS source not only 
become a primary location for PN production, but also are susceptible to PN-
induced oxidative damage due to their enriched thiol and iron-rich structures 
within the electron transport chain (ETC). In addition, the biochemical properties 
of PN enable it to diffuse out of the mitochondria to induce further oxidative 
damage to the cell membrane and cellular proteins. This increase in oxidative 
stress during the first 12 hrs, induces cellular oxidative damage by LP, protein 
oxidation and protein nitration. The calpain-mediated proteolysis displays a 
biphasic activity probably as a result of an initial partial PN-mediated inhibition of 
calpain. However, as this subsides, the extensive compromise of Ca2 
homeostasis in the mitochondrion and the rest of the cell becomes manifest and 
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calpain activity is free to reach its peak. In the end, calpain-mediated cytoskeletal 
degradation becomes a final common pathway leading to neuronal cell death. 
The findings of this study strongly support the concept of an important 
pathophysiological role of PN-mediated oxidative damage following TBI. 
Peroxynitrite-induced oxidative damage and calpain activation interact and are 
probably responsible for much of the secondary injury and neurodegeneration 
that occurs. If so, then PN-targeted antioxidants should be neuroprotective. 
However, the combination of a PN-targeted antioxidant and a calpain inhibitor 
might have a better neuroprotective action than either approach alone. Future 
studies will explore these possibilities. Copyright © Ying Deng 2007.  
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Figure 2.6 Hypothetical interrelationship between PN-induced oxidative damage 
in neuronal mitochondria and the rest of the neuron, compromise of Ca2+ 
homeostasis, calpain-mediated proteolysis and neurodegeneration. Our results 
suggest that PN-induced oxidative damage plays a key role in the post-traumatic 
secondary injury, which leads to exacerbation of Ca2+ overload, calpain 
proteolysis of cytoskeleton and other cellular proteins and neurodegeneration. 
See Discussion for a further description. 
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Chapter Three 
Tempol in Its Ability to Scavenge Free Radicals, Ameliorate Mitochondrial 
Dysfunction and Inhibit Calpain Activity 
 
Introduction 
 Nitroxide antioxidants, such as tempol (4-hydroxy-2,2,6,6-
tetramethylpiperidine-1-oxyl, see Figure 3.1), are generally described in the 
literature as potent metal-independent superoxide dismutase (SOD) mimics with 
better membrane permeability and potency (Samuni, Krishna et al. 1989; 
Krishna, Russo et al. 1996). Nitroxides have been shown to quench superoxide 
radical (O2• ⎯) to eventually produce hydrogen peroxide and oxygen just like 
SOD. Moreover, nitroxides prevent oxidative damage by removing superoxide 
radical (O2• ⎯) catalytically rather than stoichiometrically. Moreover, six-membered 
cyclic nitroxides such as tempol react faster as an antioxidant than corresponding 
five-membered ring nitroxides (Samuni, Krishna et al. 1990). As often studied in 
biological systems, nitroxides also have the ability to react with lipid peroxidation 
(LP)-derived intermediates such as alkoxyl radical and peroxyl radical.  
Furthermore, they can act as  mild oxidizing agents to prevent the cycling of 
transition medal irons (Fe2+ Fe3+) and thereby inhibit the production of hydroxyl 
radicals (•OH) via in Fenton-type reaction (Zeltcer, Berenshtein et al. 1997).  
More recently, it has been shown that tempol can catalytically decompose 
the peroxynitrite (PN) free radicals nitrogen dioxide (•NO2) and carbonate (•CO3).  
High-performance liquid chromatography (HPLC) analysis measuring the 
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intermediates of the reactions between tempol and PN-induced phenolic nitration 
suggested that oxidized forms of tempol can exchange among themselves 
without depletion in the reaction with PN-derived free radicals, which makes 
tempol a potent catalytic antioxidant (Carroll, Galatsis et al. 2000).  
 Thus, because of its multiple antioxidant properties, and its membrane 
permeability, tempol or similar compounds may have considerable therapeutic 
values in protection against cytotoxicity that involves oxidative damage. In vivo 
studies have indicated that tempol provides protection against X-ray-induced 
DNA damage, or other radiation oncology (DeGraff, Krishna et al. 1992; Hahn, 
Krishna et al. 1994). Tempol was also suggested to reduce PN-generated 
nitration, decrease poly ADP-ribose synthetase (PARS) activation, as well as 
reduce infarct volume and hyperactivity in ischemic experimental models 
(Cuzzocrea, McDonald et al. 2000; Rak, Chao et al. 2000; Kato, Yanaka et al. 
2003). Moreover, tempol was shown to reduce the pathophysiology of acute 
subdural hematoma (ASDH) (Kwon, Chao et al. 2003). In a Parkinson’s disease 
model, tempol was indicated to attenuate malonate and 1-methyl-4-phenyl-
1,2,5,6 tetrahydropyridine (MPTP)-induced neurotoxicity (Matthews, Klivenyi et 
al. 1999). Furthermore, it has been shown that tempol can improve tissue sparing 
and locomotor outcome after spinal cord injury (SCI) (Hillard, Peng et al. 2004).  
Finally, tempol has been shown to limit edema formation, blood-brain barrier 
(BBB) disruption and to improve functional recovery (Beit-Yannai, Zhang et al. 
1996; Zhang, Shohami et al. 1998).  In the latter studies, the mechanism of the 
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neuroprotective antioxidant action was completely attributed by the authors to 
superoxide scavenging.  
 The present study was undertaken in the controlled cortical impact (CCI) 
mouse traumatic brain injury (TBI) model to examine the possibility that tempol’s 
neuroprotective efficacy in acute TBI also involves inhibition of PN-mediated 
oxidative damage in brain tissue, mitochondria and downstream amelioration of 
calpain-mediated cytoskeletal breakdown. As demonstrated in our previous 
study, the early increase of oxidative damage in mitochondrial proteins paralleled 
to that in the cortical homogenate ipsilateral to the injury, which also coincided 
with the time course of mitochondrial dysfunction following the injury (Chapter 2; 
Singh, Sullivan et al. 2006a, see Appendix I and II). This strongly suggests the 
idea that mitochondria are the primary source and target of PN upon 
mitochondrial calcium uptake in the CCI model (Singh, Sullivan et al. 2006a). 
Moreover, as also indicated in our time course study on cellular changes 
triggered by TBI in the CCI model, the peak of oxidative damage at 1 hr after 
injury preceded both the peak of calpain activity at 24 hrs and 
neurodegeneration, measured by silver staining, at 48 hrs (Deng, Thompson et 
al. 2007). Therefore, the current experiments were conducted to investigate 
tempol’s ability to reduce post-traumatic PN-induced oxidative damage, 
mitochondrial dysfunction and calpain-mediated cytoskeletal degradation in order 
to establish a mechanistic linkage between these successive pathophysiological 
events.   
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Figure 3.1 Chemical structure of tempol. 
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Materials and Methods 
 
 All the surgical, injury and animal care protocols described below have 
been approved by the University of Kentucky Institutional Animal Care and Use 
Committee, and are consistent with the animal care procedures set forth in the 
guidelines of the U.S. Public Health Service Policy on Humane Care and Use of 
Laboratory Animals. 
 
Mouse Model of Controlled Cortical Impact (Focal) Traumatic Brain Injury 
 Young adult male CF-1 mice (Charles River, Portage, MI) weighing 29-
31g were used in this study. The mice were anesthetized with isoflurane (3.0%), 
shaved, and then placed in a stereotaxic frame (David Kopf Instruments, 
Tujunga, CA). Throughout the surgery, the mice were provided with constant 
isoflurane (SurgiVet, 100 Series) and oxygen (SurgiVet, O2 flowmeter, 0-4Lpm).  
The head was positioned in the horizontal plane of a stereotaxic frame with the 
nose bar set at zero. We firstly produced a 4mm craniotomy lateral to the sagittal 
suture, and centered between lambda and bregma.  A cortical contusion was 
produced on the exposed cortex (the anterior-posterior coordinate for the 
epicenter of the injury was  Bregma -2.0mm) using a pneumatically-controlled 
impactor device (Precision System Instruments TBI-0200 Impactor, Lexington, 
KY) similar to that previously described (Sullivan, Bruce-Keller et al. 1999; 
Sullivan, Thompson et al. 1999; Hall, Sullivan et al. 2005) except that the current 
device utilizes a unique contact sensor mechanism that ensures accurate and 
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reliable determination of cortical surface prior to initiating the injury sequence. 
This results in increased accuracy and reproducibility in regards to the CCI injury 
compared to that produced by earlier CCI impactors.  In the present studies, the 
impactor containing a 3mm diameter rod tip compressed the cortex at 3.5m/sec 
to a depth of 1mm with a dwell time of 50msec to produce a severe injury. After 
surgery and injury, a 4mm disk made from dental cement (Dentsply Trubyte) was 
placed over the craniotomy site and adhered to the skull using cyanoacrylate. In 
order to prevent immediate post-traumatic hypothermia, following the suturing of 
the skin, mice were placed in a Hova-Bator incubator (37°C, model 1583, Randall 
Burkey Co) until them regained consciousness (determined by the regain of the 
righting reflex and increased mobility). The injured mice were allowed to survive 
from 1 hr to 48 hrs depending on their experimental group. For the 
immunoblotting studies (measurements of oxidative damage marker and 
cytoskeletal degradation, see below), the N for each treatment group was 8 
animals; whereas for the mitochondrial studies, the N for each treatment group 
was 6 (3 mice were pooled together to create 1 N), based upon our experience 
with the variability seen with these measurements in previous studies (Kupina, 
Detloff et al. 2003; Hall, Detloff et al. 2004; Hall, Sullivan et al. 2005).   
 
Tempol Preparation 
 Tempol was purchased from Sigma-Aldrich (Milwaukee, WI, U.S.A) and 
freshly prepared in 0.9% saline before abdominal intraperitoneal (i.p.) injection. In 
our dose-response study we experimented with different dosages at 3mg/kg, 
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10mg/kg, 30mg/kg, 100mg/kg and 300mg/kg (n=8), which well covered the 
dosage range that have been explored in related neuropathological studies and 
pilot studies (Beit-Yannai, Zhang et al. 1996; Mota-Filipe, McDonald et al. 1999; 
Behringer, Safar et al. 2002). Used as control for the tempol treatment group 
(injured-tempol), 9% saline was given as vehicle to animals (injured-vehicle). 
Another control group was composed of sham animal who were subjected to 
craniotomy but no contusion injury and treated with vehicle (sham-vehicle). Sham 
animals treated with tempol (n=8) in an initial dose-response study were also 
tested, and indicated no difference from sham-vehicle group (data not shown). 
There was zero mortality in the current study. 
 
Tissue Extraction and Protein Assay 
 At the selected time points for the respective analysis (1 hr, 6 hrs, 12 hrs 
or 24 hrs), the sham or injured-vehicle, injured-tempol mice were deeply 
overdosed with sodium pentobarbital (200mg/kg i.p.). Following decapitation, the 
ipsilateral cortical area of interest as was rapidly dissected on an ice-chilled stage 
as previously described (Deng, Thompson et al. 2007). Immediately following 
dissection, samples were transferred into pre-cooled Triton lysis buffer (1% triton, 
20mM tris HCL, 150mM NaCl, 5mM EGTA, 10mM EDTA, 10% glycerol) with 
protease inhibitors (Complete MiniTM Protease Inhibitor Cocktail tablet). Samples 
were then briefly sonicated and vortexed at 14,000rpm for 30 minutes at 4°C, 
and the supernatants were collected for protein assay. Protein concentration was 
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determined by Bio-Rad DC Protein Assay, with sample solutions diluted to 
contain 1mg/ml of protein for immunoblotting. 
 
Slot-Blotting Analysis of Oxidative Damage (3NT) 
 To measure 3-nitrotyrosine (3NT), an aliquot of each ipsilateral cortical 
protein (2µg) or isolated mitochondrial protein was diluted with 200µl of tris-
buffered saline (TBS), and transferred to a Protran (0.2µm) nitrocellulose 
membrane (Schleicher & Schuell, Dassel, Germany) by a Minifold II vacuum slot 
blot apparatus (Schleicher & Schuell). After the samples were loaded into the 
slots, they were allowed to filter through the membrane by gravity (no vacuum). 
Each slot was then washed with 200µl TBS which was allowed to filter through 
the membrane again. The membranes were then disassembled from the 
apparatus, and incubated in a TBS blocking solution with 5% milk for 1 hr at 
room temperature. For the detection of 3NT, a rabbit polyclonal anti-nitrotyrosine 
antibody (Upstate Biotechnology, MA, USA) was used at a dilution of 1:2000 in 
TBST blocking solution with 5% milk for overnight at 4°C. Preliminary 
experiments established protein concentration curves in order to ensure that 
quantified blots were in the linear range. From the results of these, we selected 
the 2µg for use based upon that amount giving blots that were well within the 
linear range. A standardized protein loading control was included on each blot to 
normalize the band densities so that comparisons could be made across multiple 
blots. All the samples were run in duplicate which were then averaged. For 3NT 
analyses, no primary antibody controls were run to verify that the oxidative 
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damage staining was specific. In addition, we ran positive controls using both 
bovine serum albumin and normal brain tissue which were exposed to PN and 
negative controls in which we pre-absorbed the primary antibodies with 3NT 
which resulted in inhibition of the 3NT staining.   
 
Mitochondrial Percoll Gradient Purification and BCA Protein Assay 
Brain cortical mitochondria were extracted as previously described with 
some modifications (Sullivan, Geiger et al. 2000; Sullivan, Dube et al. 2003). 
Following decapitation, ipsilateral cortex was quickly removed and pooled from 3 
mice. The cortices were placed in a Potter-Elvejhem homogenizer containing five 
times the volume of ice-cold isolation buffer (5 fold buffer to tissue) with 1 mM 
EGTA (215mM mannitol, 75mM sucrose, 0.1% BSA, 20mM HEPES, 1mM 
EGTA; pH adjusted to 7.2 with KOH) and the homogenates were subjected to 
differential centrifugation at 4°C. First, the homogenate was centrifuged twice at 
1300 X g for 3 min in an Eppendorf microcentrifuge at 4°C to remove cellular 
debris and nuclei. The pellet was discarded and the supernatant further 
centrifuged at 13,000 X g for 10 min. The crude mitochondrial pellet obtained 
after differential centrifugation were then subjected to nitrogen decompression to 
release synaptic mitochondria, using a nitrogen cell disruption bomb, cooled to 
4°C under a pressure of 1200 psi for 10 min (Sullivan, Dube et al. 2003; Brown, 
Sullivan et al. 2004; Kristian, Hopkins et al. 2006). Following nitrogen disruption 
the mitochondria were suspended in 3.5ml of 15% percoll and further laid on a 
two preformed layers consisting of 3.5ml of 24% percoll and 3.5ml of 40% Percoll 
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in 13ml ultra-clear tubes. The gradient was centrifuged in fixed angle rotor at 
30,400 X g for 10 min at 4°C. The fraction accumulated at the interphase of 40% 
and 24% percoll was carefully removed and diluted with isolation buffer without 
EGTA, then centrifuged at 12,300 X g for 10 min at 4°C. The supernatants were 
carefully removed, the pellet resuspended in isolation buffer without EGTA and 
centrifuged at 13,000 X g for 10 min at 4°C. The mitochondrial pellets at the 
bottom were then transferred to microcentrifuge tubes and topped off with 
isolation buffer without EGTA and centrifuged at 10,000 X g for 5 min at 4°C to 
yield a tighter pellet. The final mitochondrial pellet was resuspended in isolation 
buffer without EGTA to yield a concentration of ~10mg/ml. The protein 
concentration was determined using the BCA protein assay kit measuring 
absorbance at 562 nm with a BioTek Synergy HT plate reader (Winooski, 
Vermont). 
 
Mitochondrial Respiration Measurement 
Mitochondrial respiratory rates were measured using a Clark-type 
electrode in a continuously stirred, sealed thermostatically-controlled chamber 
(Oxytherm System, Hansatech Instruments Ltd) maintained at 37°C as 
previously described (Sullivan, Geiger et al. 2000; Jiang, Sullivan et al. 2001; 
Sensi, Ton-That et al. 2003; Sullivan, Dube et al. 2003). Twenty five to 40µg of 
isolated mitochondrial protein  was placed in the chamber containing 250µl of 
KCl-based respiration buffer (125mM KCl, 2mM MgCl2, 2.5mM KH2PO4, 0.1% 
BSA, 20mM HEPES at pH 7.2) and allowed to equilibrate for 1 min. This was 
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followed by the addition of complex-I substrates, 5mM pyruvate and 2.5mM 
malate, to monitor state II respiratory rate. Two boluses of 150µM ADP were 
added to the mitochondria to initiate state III respiratory rate for 2 min followed by 
the addition of 2µM oligomycin to monitor state IV respiration rate for an 
additional 2 min. For the measurement of uncoupled respiratory rate, 2µM p-
trifluoromethoxy carbonyl cyanide phenyl hydrazone (FCCP) was added to the 
mitochondria in the chamber and oxygen consumption was monitored for another 
2 min. This was followed by the addition of 10mM succinate to monitor complex 
II-driven respiration. The respiratory control ratio (RCR) was calculated by 
dividing state III oxygen consumption (defined as the rate of respiration in the 
presence of ADP, second bolus addition) by the state IV oxygen consumption 
(rate obtained in the presence of oligomycin). Fresh mitochondria were prepared 
for each experiment and used within 4 hr. 
 
Western-Blotting Analysis of Calpain-Mediated Cytoskeletal Degradation 
 To measure calpain-mediated α-spectrin proteolysis, aliquots of each 
cortical sample (5µg) were run on a SDS/PAGE Precast gel (3-8% Tris-Acetate 
CriterionTM XT Precast gel, Bio-Rad) and then transferred to a nitrocellulose 
membrane using a semi-dry electro-transferring unit set at 15V for 15min. 
Preliminary experiments established protein concentration curves in order to 
ensure that quantified bands were in the linear range as measured with the Li-
Cor Odyssey Infrared Imaging System.  The membranes were incubated in a 
TBS blocking solution with 5% milk for 1 hr at room temperature. For the 
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detection of α-spectrin and its breakdown products, a mouse monoclonal anti-α-
spectrin antibody (Affiniti FG6090) was used at a dilution of 1:5000 in TBST 
blocking solution with 5% milk for overnight at 4°C. A goat anti-mouse secondary 
conjugated to an infrared dye (1:5000, IRDye800CW, Rockland) was then 
applied for 1 hr at room temperature. After drying, the membranes were then 
imaged and quantified using the Li-Cor Odyssey Infrared Imaging System. A 
standardized protein loading control was included on each blot to normalize the 
band densities so that comparisons could be made across multiple blots (Hall, 
Sullivan et al. 2005). This was made up of pooled brain tissue protein collected 
from previously run TBI mice which gave strong bands corresponding to the 
280kD parent α-spectrin, the 150kD and the 145kD breakdown products.  The 
amount of protein in the loading control had been previously determined and 
shown to be within the linear range as measured with the Li-Cor Odyssey 
Infrared Imaging System.  Following the transfer, the gels were stained with 
Coomassie Blue to verify even transfer. All the samples were run in duplicate and 
averaged. 
 
Statistical Analysis 
 For all of the time course analyses, we used Statview 5.0 to perform a 
one-way analysis of variance (ANOVA), followed by Student-Newman-Keuls 
(SNK) post-hoc analysis to determine the significance of differences between the 
non-injured sham group and injured vehicle treated vs. injured tempol treated 
groups. For the ANOVA, a p<0.05 was required to establish a statistically 
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significant difference across the groups. However, for the post-hoc SNK analysis, 
the program determined significance based upon a correction for multiple 
comparisons.  
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Results 
 
Dose-Response Study of the Effect of Tempol on Protein Nitration 
 The level of protein nitration in cortical tissue homogenate was assessed 
by quantitative antibody-based immuno-slotblotting. Figure 3.2 shows the results 
of a dose-response analysis examining ipsilateral cortical protein nitration level 
following TBI (n=8). Five different single i.p. dosages were administrated 
abdominally to the mice 15 min after cortical contusion. All mice were euthanized 
1 hr after when PN-induced oxidative is at its peak (Deng, Thompson et al. 
2007). The ANOVA showed a significant difference across the experimental 
groups [F(6,49)=3.397; p<0.01]. Post-hoc analysis revealed that the injured mice 
treated with vehicle (0.9% saline) showed about 90% of increase in 3NT (a 
specific marker for PN) level (p=0.007). In comparison to that, three highest 
dosages of tempol (30mg/kg, 100mg/kg and 300mg/kg) significantly reduced the 
3NT level comparing to injured mice treated with vehicle mice. However, there 
was no significant difference among different dosage groups. The highest dose 
of tempol treatment in the current study (300mg/kg) was able to completely 
prevent any post-traumamtic increase in 3NT level over the sham baseline level. 
Therefore, this dosage was chosen in the following studies. Another control 
group, in which sham was treated with tempol (n=8) showed no difference from 
sham vehicle-treated group (data not shown).  
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Figure 3.2 Tempol treatment studies using quantitative slotblotting in ipsilateral 
cortical traumatic brain injury tissues showing dose-response changes in protein 
nitration (3-nitrotyrosin, 3NT). Single dose of tempol was administrated i.p. to 
animals 15 min followed by sacrifice at 1 hr after TBI. The three highest doses at 
30mg/kg, 100mg/kg and 300mg/kg significantly reduced 3NT level, a specific 
marker for PN-induced oxidative damage, in ipsilateral cortical tissues. N = 8 
animals per treatment group; values = mean + standard error; one-way ANOVA 
and Student-Newman-Keuls post hoc test: A p < 0.01 vs. sham; one-way ANOVA 
and Student-Newman-Keuls post hoc test: B p < 0.01 vs. vehicle.  
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Effect of Tempol on Mitochondrial Respiration 
 Isolated cortical mitochondrial protein measured by BCA protein assay 
was divided to run for mitochondrial respiratory assay and quantitative immuno-
slotblotting respectively (see Materials and Methods). Mitochondrial oxygen 
consumption was measured by a Clarke-type electrode. In this study, mice (n=6) 
were treated with a single i.p. dose either vehicle or tempol (300mg/kg) 15 min 
after injury, followed by euthanasia 12 hrs after TBI. This time point was selected 
since it we had previously shown that it represents the peak of mitochondrial 
dysfunction in the CCI model (Singh, Sullivan et al. 2006a, see Appendix I). 
Cortical mitochondria were isolated and purified followed by incubation in the 
constantly-stirred sealed chamber. The oxygen consumption rate of each step 
was recorded by the slope of the oxygen respiration trace upon substrates 
addition. Figure 3.3A indicates the respiratory rates comparison among sham 
vehicle-treated, injured vehicle-treated and injured tempol-treated groups. Two 
doses of ADP after pyruvate and malate initiated the respiration of mitochondria. 
There was a significant difference across the sham, injured vehicle and injured 
tempol-treated groups [F(2,15)=4.339; p<0.05]. Post-hoc analysis showed that 
injured vehicle-treated mitochondria displayed significantly decreased complex I-
driven state III respiration compared to sham, indicating impaired mitochondrial 
respiratory function. In contrast, the mitochondria isolated from the tempol-
treated mice showed a complete maintenance of normal state III respiration 
which was significantly higher than the vehicle-treated mice. There was no 
significant difference detected in state IV respiration among groups upon 
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oligomycin addition. The inhibition of ATP synthase generally eliminated most of 
the respiratory activity.  
A mitochondrial uncoupler, FCCP, was added to initiate maximal 
mitochondrial respiration state V by inducing mild proton leak into mitochondria. 
This analysis also showed a significant difference across the treatment groups 
[F(2,15)=6.894; p<0.001]. Post-hoc testing showed that the injured vehicle-
treated group displayed significantly reduced respiration rate comparing to the 
sham group, suggesting impairment of the electron transport chain (ETC). 
However, mitochondria isolated from tempol-treated mice were able to show 
significantly improved state V respiration compared to the vehicle-treated group. 
Complex II-driven state VI respiration was tested by adding the complex II 
substrate succinate. There was no significantly difference observed among three 
treatment groups, suggesting that complex II and the downstream complexes 
were relatively healthy, in contrast to complex I which was impaired.   
 Figure 3.3B displays the respiratory controlled ratio (RCR) of isolated 
mitochondria from the three different treatment groups which the ANOVA showed 
was significantly different [F(2,15)=11.910; p<0.001]. The RCR indicates how 
well oxygen consumption is coupled to ATP generation and is often used as the 
index of mitochondrial function (healthy: RCR>5). In Figure 3.3B, mitochondria 
from injured mice without drug treatment shows a mean RCR=3.7, which was 
significantly lower than the sham group, RCR=7.3. The tempol-treated group 
demonstrated a mean RCR=5.6, suggesting that the mitochondria remain on 
average within the healthy range (i.e. >5.0). The tempol treated mean was 
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significantly higher than vehicle-treated group. However, although tempol 
treatment was able to improve mitochondrial function to healthy level, the RCR in 
the injured tempol-treated group was significantly lower than that in the sham 
group, suggesting that mitochondrial function was not fully recovered. 
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Figure 3.3 Effect of optimal single dose tempol treatment on mitochondrial 
respiration in ipsilateral cortical traumatic brain injury tissues measured by 
Clarke-type electrode. A. Single i.p. abdominal dose of tempol (300mg/kg) 
significantly improved state III (ADP) and state V (FCCP) respiration comparing 
to vehicle-treated group. B. Tempol treated group showed significant recovery of 
respiratory controlled ration (RCR) comparing to vehicle-treated group. N = 6 
animals per treatment group; values = mean + standard error; one-way ANOVA 
and Student-Newman-Keuls post hoc test: A p < 0.05 vs. sham; one-way ANOVA 
and Student-Newman-Keuls post hoc test: B p < 0.05 vs. vehicle. 
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Effect of Tempol on Mitochondrial Oxidative Damage 
 Isolated cortical mitochondrial protein was measured by BCA protein 
assay and 2µg of each sample was run on quantitative antibody-based immuno-
slotblots. Figure 3.4 demonstrates mitochondrial 3NT level at 12 hrs after injury 
subjected to different treatments (n=4). The ANOVA revealed a significant 
difference across the treatment groups [F(2,9)=4.843; p<0.05]. Post-hoc analysis 
showed that even though the 3NT level in the injured vehicle-treated group was 
increased comparing to sham group, this increase was not significant.  
Consistent with this observation, we had previously found that while a significant 
increase in 3NT level in mitochondrial proteins is seen as early as 30 min after 
injury, and out to at least 3 hrs, the persistent mean increase in 3NT at 12 hrs 
after TBI loses significance in comparison to sham (Singh, Sullivan et al. 2006a). 
Nevertheless, in the injured tempol-treated group, 3NT level was significantly 
lower than the injured vehicle-treated group by 55%.  Moreover, the mean 3NT 
level in the injured tempol-treated group was also lower than that seen in the 
sham group, but this difference was not significant.   
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Figure 3.4 Effect of optimal single dose tempol treatment on mitochondrial 
oxidative damage in ipsilateral cortical traumatic brain injury tissues measured by 
quantitative slotblotting. Single i.p. abdominal injection of tempol (300mg/kg) 
significantly decreased 3NT level in comparison to vehicle-treated group in 
cortical mitochondrial proteins. N = 4 animals per treatment group; values = 
mean + standard error; one-way ANOVA and Student-Newman-Keuls post hoc 
test: A p < 0.05 vs. sham; one-way ANOVA and Student-Newman-Keuls post hoc 
test: B p < 0.05 vs. vehicle. 
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Effect of Single Dose of Tempol on Calpain-Mediated α-Spectrin Breakdown 
 Post-traumatic cytoskeletal degradation was measured by antibody-based 
immuno-westernblotting detecting α-spectrin breakdown products in cortical 
tissues ipsilateral to the injury. Mice were treated with a single dose of vehicle or 
tempol (300mg/kg) 15 min after TBI, and were killed at 1 hr or 6 hrs post-injury 
(n=8/group). Figure 3.5A shows that there was statistically significant difference 
across the three groups for the calpain-specific SBDP145 analysis 
[F(2,21)=5.590; p<0.05], but not in the case of the SBDP150 which is generated 
by both calpain and caspase 3 (Wang 2000). Post-hoc testing revealed that there 
was a significant increase in SBDP145 at 1 hr post-injury in the injured vehicle-
treated group compared to the sham vehicle-treated group. However, tempol 
treatment significantly reduced SBDP145 compared to vehicle treatment by 45%.  
Figure 3.5B displays the level of SBDPs at 6 hrs after TBI with or without 
tempol treatment. Both SBDPs showed significant increase compared to the 
sham group. Although there was a slight decline of both SBDPs in the injured 
tempol-treated group compared to vehicle-treated group, the decrease was not 
significant (p<0.01). The magnitude of both SBDPs in injury groups at 6 hrs post-
injury was higher than that at 1 hr post-injury, which indicated there is 
progressive increase of calpain activity over time following TBI until it reaches its 
peak at 24 hrs in the CCI model (Deng, Thompson et al. 2007). The short term 
effect of tempol in reducing SBDP145 at 1 hr but not 6 hrs post-injury 
encouraged us to explore a tempol treatment regimen involving repeated doses 
administered over the course of the oxidative damage.  
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Figure 3.5 Effect of optimal single dose tempol treatment on calpain-mediated α-
spectrin breakdown in ipsilateral cortical traumatic brain injury tissues measured 
by quantitative westernblotting. A. Tempol treatment significantly reduced 
SBDP145 comparing to vehicle treatment, but here was no change in SBDP150 
at 1 hr post-injury. B. Tempol treatment was not able to decrease SBDPs at 6 hrs 
after TBI. N = 8 animals per treatment group; values = mean + standard error; 
one-way ANOVA and Student-Newman-Keuls post hoc test: A p < 0.05 vs. sham; 
one-way ANOVA and Student-Newman-Keuls post hoc test: B p < 0.05 vs. 
vehicle. 
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Effect of Multiple Dose of Tempol on Calpain-Mediated α-Spectrin Breakdown 
 In this study, multiple doses of vehicle or tempol (300mg/kg) were 
administrated i.p. to mice at 15 min, 3 hrs, 6hrs, 9 hrs and 12 hrs post-injury 
followed by euthanasia at 24 hrs when calpain-mediated SBDPs reach their peak 
in the CCI model (Deng, Thompson et al. 2007). As indicated in Deng et al, at 24 
hrs post-injury, the magnitude of calpain-specific SBDP145 is more than twice  
as much as that of calpain/caspase 3-produced SBDP150, suggesting a the 
dominant role of calpain in post-traumatic proteolysis. However, at 24 hrs post-
injury the difference across groups for both SBDPs is significant; for SBDP145 
[F(2,20)=16.513; p<0.0001] and for SBDP150 [F(2,20)=5.241; p<0.05]  In Figure 
3.6, tempol treatment decreased both SBDPs significantly compared to vehicle 
treatment. The effect on SBDP150 was essentially complete since the magnitude 
of non-specific SBDP150 is much lower than that of calpain-specific SBDP145. 
However, although tempol treatment also reduced SBDP145 by 45% compared 
to the injured vehicle-treated group, the SBDP145 level in the injured tempol-
treated group remained significantly elevated compared to the sham level, 
suggesting that proteolytic damage induced by calpain was not fully inhibited 
even with this repeated dose treatment regimen.  
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Figure 3.6 Effect of multiple dose tempol treatment on calpain-mediated α-
spectrin breakdown in ipsilateral cortical traumatic brain injury tissues measured 
by quantitative westernblotting. Multiple doses of tempol were administrated at 
15 min, 3 hrs, 6 hrs, 9 hrs and 12 hrs before sacrifice of the animals. In injured 
vehicle-treated group, both SBDPs were significantly increased than sham group 
with higher magnitude of SBDP145 elevation. Multiple i.p. injection of tempol 
(300mg/kg) significantly reduced both SBDPs in comparison to vehicle-treated 
group.  N = 8 animals per treatment group; values = mean + standard error; one-
way ANOVA and Student-Newman-Keuls post hoc test: A p < 0.05 vs. sham; 
one-way ANOVA and Student-Newman-Keuls post hoc test: B p < 0.05 vs. 
vehicle. 
 
 92
Therapeutic Window of Multiple Dose of Tempol Treatment Measured by 
Calpain-Mediated α-Spectrin Breakdown 
  
A therapeutic window study next conducted in which the onset of tempol 
multiple dose treatment was delayed from the 15 min post-injury tested earlier 
(Figure 3.6 above) to either by 1 hr or 2 hrs. We administered multiple i.p. doses 
treatment starting at 1 hr or 2 hrs post-injury, with four additional bolus i.p. 
injections every 3 hrs. Animals were then studied at 24 hrs after the first injection. 
In Figure 3.7A, a 1 hr delay in treatment with tempol showed no effect in both 
SBDP145 and SBDP150. Both SBDPs remained at similar level as the injured 
vehicle-treated group. Figure 3.7B displayed 2 hrs delay treatment of tempol, 
which showed similar outcome. Although postponing the tempol treatment did not 
show any protection, it did not exacerbate the post-traumatic cytoskeletal 
proteolysis measured by calpain-mediated SBDPs.  
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Figure 3.7 Therapeutic window study using multiple doses of tempol measured 
by quantitative westernblotting. A. The multiple i.p. tempol treatment regimen 
was postponed by 1 hr after injury, and animals were sacrificed at 25 hrs. B. The 
multiple i.p. tempol treatment regimen was postponed by 2 hrs after injury, and 
animals were sacrificed at 26 hrs. N = 8 animals per treatment group; values = 
mean + standard error; one-way ANOVA and Student-Newman-Keuls post hoc 
test: A p < 0.05 vs. sham; one-way ANOVA and Student-Newman-Keuls post hoc 
test: B p < 0.05 vs. vehicle 
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Discussion 
 
 The current study applied a pharmacological approach in elucidation of 
the pathophysiological relationship of PN-induced oxidative damage, 
mitochondrial dysfunction and calcium-activated, calpain-mediated cytoskeletal 
degradation by testing the ability of the multi-mechanistic nitroxide antioxidant 
tempol, to inhibit these secondary injury events in the CCI TBI mouse model.  
Our previous time course study defined the dynamic changes of PN production, 
oxidative mitochondrial damage, calpain-mediated proteolysis and 
neurodegeneration, and their temporal inter-relationship (Singh, Sullivan et al. 
2006a, see Appendix I; Deng, Thompson et al. 2007). The time course study 
strongly indicates that PN has a pivotal role in the secondary injury following TBI, 
and suggests that scavenging of PN or its derived free radicals is a plausible 
neuroprotective therapeutic target. A thorough analysis was conducted to 
evaluate the therapeutic effect of tempol in regard to its ability to ameliorate 
mitochondrial dysfunction and to preserve cytosolic Ca2+ homeostasis and as a 
result to reduce calpain-mediated proteolysis. 
 
Tempol Effect on PN-Mediated Oxidative Damage in the CCI-TBI Mouse Model 
 The neuroprotective effect of tempol was previously explored in a closed 
head rat TBI model. Tempol showed cerebroprotective effects by limiting edema 
formation, ameliorating blood-brain barrier (BBB) disruption and improving 
functional recovery (Beit-Yannai, Zhang et al. 1996; Zhang, Shohami et al. 1998). 
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In these studies, it was suggested that the neuroprotective effects of tempol was 
due to its catalytic scavenging of superoxide radicals. However, oxidative 
damage markers were not examined, and more recent experiments have 
suggested that an important antioxidant property that may contribute significantly 
to the inhibition of post-traumatic oxidative damage in brain tissue involves a 
catalytic scavenging of the PN-derived radicals •NO2 and •CO3.   
A stable biomarker of PN oxidative damage to proteins involves the 
nitration of protein tyrosine residues which produces the product 3-nitrotyrosine 
(3NT). Although it was previously suggested that nitric oxide (NO•) could give 
rise to tyrosine nitration, subsequent analyses have shown that this is probably 
caused by PN-derived •NO2. Alternatively, PN is able to react with SOD to form 
nitronium ion (NO2+)-like intermediate which may also cause tyrosine residue 
nitration (Ischiropoulos, Zhu et al. 1992). In the current study, we used antibody-
based quantitative immuno-slotblotting detection of the PN-specific marker 3-
nitrotyrosine (3NT) to investigate the effect of tempol on PN-induced oxidative 
damage. Animals were administered with single dose of tempol i.p. at 15 min and 
sacrificed at 1 hr after injury when PN-induced oxidative damage is at its peak 
(Deng, Thompson et al. 2007). A significant increase in cortical 3NT level in 
vehicle treated group compared to sham was observed. Comparing to vehicle 
treated group, tempol treatment 30mg/kg, 100mg/kg and 300mg/kg significantly 
decreased 3NT level in the cortical tissue ipsilateral to the injury showing that 
tempol has a wide range of antioxidant potency, and that scavenging of PN-
derived •NO2 may be key aspect of tempol’s antioxidant mechanism in vivo. 
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Tempol Effect on Mitochondrial Respiration and Oxidative Damage in the CCI-
TBI Mouse Model 
 Mitochondria have long been suggested to be a main resource for ROS. 
The mono-electron transport through the mitochondrial ETC spins off oxidants 
(mainly O2• ⎯ ) as by-products during metabolism (Shigenaga, Hagen et al. 1994; 
Herrero and Barja 1997). Unknown components of ETC complex I and 
ubiquinone of complex III are indicated to be the major sites of ROS generation. 
It has been proposed that the complex I flavin mononucleotide (FMN) group was 
the major ROS generating site (Liu, Fiskum et al. 2002), whereas others 
hypothesize that mitochondrial generated O2• ⎯ preferably occurs at the lever of 
coenzyme Q (Kowaltowski, Castilho et al. 1995). More recently, a novel Ca2+-
dependent isoform of nitric oxide synthase (NOS) was identified within 
mitochondria which is activated upon mitochondrial Ca2+ uptake (Giulivi 1998; 
Tatoyan and Giulivi 1998). Although NO• has been suggested to itself be toxic, 
most investigators now believe that the damaging effects of NO• are mediated by 
PN, which is formed by the diffusion rate-limited reaction of NO• with O2• ⎯ 
(Beckman and Koppenol 1996). Evidence has been obtained that the NO•-
dependent inactivation of iron-sulfur centers was in fact mediated by PN (Castro, 
Rodriguez et al. 1994; Hausladen and Fridovich 1994). PN-derived radicals are 
extremely reactive with bio-molecules, including lipids, proteins and DNAs 
(Murphy, Packer et al. 1998; Radi 1998; Hall, Detloff et al. 2004). The discovery 
of the mitochondrial isoform of NOS exposes mitochondria as the major source 
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and therefore a target for PN-mediated oxidative damage (Packer and Murphy 
1994).  
Mitochondrial membrane integrity and compartmentalization is important 
in maintaining normal respiratory function. However, high in content in 
polyunsaturated fatty acids (PUFAs) makes brain mitochondria a vulnerable 
target for free radicals attack and lipid peroxidation (LP). PN was reported to 
increase mitochondrial proton leak but was irreversible by mPTP blocker, 
cyclosporine A (CsA) (Brookes, Land et al. 1998). Echtay et al proposed that 
4HNE, the end product of LP, acts as secondary messenger to induce proton 
leak through uncoupling proteins (UCPs) and adenine nucleotide translocator 
(ANT) (Echtay, Esteves et al. 2003). In additional to lipid damage, mitochondrial 
proteins were indicated to be inactivated by oxidative damage in various 
neurodegenerative diseases (Butterfield and Lauderback 2002; Gibson and 
Huang 2004; Martin, Rosenthal et al. 2005). In a study in which mitochondria 
were exposed to PN toxicity as well as Ca2+, the investigators observed the PN-
induced membrane protein thiol cross-linking correlated to mitochondrial swelling 
(Gadelha, Thomson et al. 1997). Moreover, proteomic identification of specific rat 
mitochondrial fraction proteins demonstrated highly oxidized key components of 
electron transport chain (ETC) 3 hrs after CCI (Opii, Nukala et al. 2007). In our 
previous study, quantitative slotblotting measurement of post-injury mitochondrial 
LP and protein nitration levels showed immediate increase of PN-induced 
oxidative damage which persists for hours after injury (Singh, Sullivan et al. 
2006a, see Appendix II). Although the level of 3NT in injured brain mitochondria 
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is still elevated, it has lost significance by 12 hrs after injury due perhaps to its 
decreased production and its possibly increased proteolytic removal (Grune, 
Reinheckel et al. 1997). In the current study, we demonstrated that the early (15 
min post-injury) tempol treatment largely reduced the 12 hrs post-injury cortical 
mitochondrial 3NT level to below baseline, and significantly lower than the 
vehicle-treated injured mitochondria. In correlation to reduced mitochondrial 
oxidative damage, mitochondrial respiration was almost completely preserved 
(Figure 3.3). Specifically, state III respiration in tempol-treated group shows full 
preservation compared to the sham group, and the RCR (state III/state IV) 
showed maintenance to within normal limits  
The complex II-driven succinate respiration showed no significant 
decrease after injury. Therefore, complex I-driven respiration possibly accounted 
for most of the impaired respiratory function observed. Complex I is a very large 
complex member with FMN redox center and many iron-sulfur centers. Hence it 
is vulnerable to oxidative inactivation. Moreover, complexes I contains seven 
mtDNA-encoded subunits out of the thirteen peptides encoded by mtDNA. 
mtDNA is also a susceptible target for oxidative damage due to its proximity to 
PN production and lack of histone protection. A recent study on CNS 
mitochondria showed a correlation between the level of oxidized mtDNA bases 
and post-traumatic impairment of respiration (Sullivan, Rabchevsky et al. 2004). 
In any event, uncontrolled oxidative damage to mitochondrial membranes, 
proteins and DNA can be detrimental to their function. Our studies showed that 
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administration of the membrane permeable tempol protects mitochondria against 
oxidative damage and improves mitochondrial function at 12 hrs post-injury.  
  
Tempol Effect on Calpain-Mediated α-Spectrin Breakdown in the CCI-TBI Mouse 
Model 
Calpain-mediated proteolysis has been implicated in many pathological 
conditions. Evidences for mitochondrial damage and cytoskeletal proteolysis 
coincide with calpain activity have been demonstrated in TBI models (Chan and 
Mattson 1999; Wang 2000). Calpain, a cysteine protease, is activated in 
response to cytosolic Ca2+ elevation. It was suggested that calpain plays a role in 
dendritic remodeling, membrane repair and resealing and after injury (Faddis, 
Hasbani et al. 1997). However, the disruption of neuronal Ca2+ homeostasis may 
result in excessive activation of calpain (Saito, Elce et al. 1993; Bartus, Elliott et 
al. 1995). In addition to that, a rat CCI model RT-PCR study revealed increased 
mRNA expression of calpain and cysteine proteases within minutes after injury 
that persisted for days post-injury (Ringger, Tolentino et al. 2004). Moreover, 
calpain has a similar temporal profile as caspases, and responses to different 
injury severities even though calpain responds to a greater degree (Thompson, 
Gibson et al. 2006; Deng, Thompson et al. 2007). Because of its extensive 
involvement in ischemia and traumatic neuronal injuries, calpain-mediate 
proteolysis is proposed as a final common pathway of neuronal cell death 
following various insults (Bartus, Elliott et al. 1995; Bartus, Dean et al. 1998).  
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Dramatic upregulation of calpain activity progresses for hours after injury, 
which provides a broad temporal opportunity for neuroprotection (Saatman, 
Graham et al. 1998; Deng, Thompson et al. 2007). Our previous work (Chapter 2 
and Deng, Thompson et al. 2007) showed that post-traumatic calpain activation 
and cytoskeletal proteolysis is preceded by PN-mediated oxidative damage, 
mitochondrial dysfunction, impairment of Ca2+ homeostasis and presumably 
intracellular Ca2+ overload and is then followed by neurodegeneration. If these 
processes are indeed linked as a series of events, then tempol treatment, which 
is known to interfere with the initiating PN-induced oxidative damage and 
mitochondrial dysfunction, should also attenuate the downstream calpain-
mediated proteolytic damage to cellular elements. We first tested this hypothesis 
through single i.p. dose tempol treatment administered immediately after CCI 
which showed an inhibitory effect on calpain activity at 1 hr post-injury. We 
accordingly conclude that the membrane permeable tempol is rapidly taken up by 
mitochondria where it prevents their oxidative damage and loss of Ca2+ buffering 
capacity leading to an attenuation of intracellular Ca2+ overload and prevention of 
calpain over-activation. However, when we waited until 6 hrs after injury, this 
protective effect observed at 1 hr was no longer apparent in the case of early 
single dose tempol treatment. This is probably due to the fact that tempol has a 
very short half-life in mice (<30 min) (Kamatari, Yasui et al. 2002). Furthermore, 
the high blood flow in cortical tissue will hasten its elimination from the injured 
brain tissue following a single dose.   
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Subsequently, we administered multiple dosages of tempol at 3 hrs 
intervals up to 12 hrs and measured its effect at 24 hrs after injury. This 
experiment showed that this more aggressive multiple dose tempol treatment 
had a partial inhibitory effect on calpain-mediated proteolysis. However, the 
therapeutic window for the achievement of this effect is disappointingly short 
since delayed initiation of tempol treatment until 1 or 2 hrs post-injury failed to 
attenuate the 24 hrs peak of calpain-mediated α-spectrin degradation. This result 
may indicate that even though PN-induced oxidative damage is a critical early 
event in post-TBI injury, the potential therapeutic practicality of its inhibition is 
limited by a short therapeutic time window.   
Alternatively, it is now well known that that oxidative stress has inhibitory 
effects on both calpain (Benuck, Banay-Schwartz et al. 1992; Guttmann, Elce et 
al. 1997; Guttmann and Johnson 1998) and caspase 3 (Lau, Arundine et al. 
2006) via oxidation of cysteine residues at the active site. Accordingly, total 
inhibition of ROS may remove the protective aspect of free radicals which may 
serve to reduce post-traumatic calpain activation together with the attenuation in 
oxidative damage to the mitochondria. This dual effect of ROS in this case, may 
be seen in the biphasic increase time course of α-spectrin degradation we 
observed which is similar to that seen in different experimental models in vitro 
and in vivo neural injury (Neumar, Meng et al. 2001; DeRidder, Simon et al. 
2006; Xiong, Rabchevsky et al. 2007). As shown by our previous study, there 
was a biphasic increase of SBDPs connected by a plateau phase between 3 hrs 
and 12 hrs. Between 12 hrs and 24 hrs, both SBDPs exhibited a greater than 
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75% elevation (Deng, Thompson et al. 2007). The sudden and significant 
increase in SBDPs began at 12 hrs which represented the outer limit of the 
measurable increase in PN-mediated 3NT (Figure 2.4). Thus, the wave of 
oxidative damage occurring between 30 min and 12 hrs post-injury while 
detrimental to the injured tissue overall may at the same time serve to limit the 
full expression of calpain activation. This two-edged sword in regards to the 
influence of PN on calcium-induced activation of calpain may explain why at best 
tempol is only partially effective at attenuating cytoskeletal degradation even 
when given soon after TBI. It may also help explain why tempol has an 
apparently very short therapeutic window in relation to inhibiting downstream 
proteolytic damage. In other words, if tempol is delayed until calpain activation is 
more established, the removal of the oxidative attenuation of calpain activity may 
lead to an exacerbation of calpain activity that may offset the benefits of the 
tempol reduction in mitochondrial oxidative damage. Further experiments are 
needed to investigate this notion. In any event, it seems clear that antioxidant 
treatment may need to be combined with other agents that more directly target 
calpain activation in order to achieve a more pronounced and practical 
neuroprotective approach. Copyright © Ying Deng 2007.  
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Chapter Four 
Effect of Tempol on Behavioral Recovery and Neurodegeneration after 
Traumatic Brain Injury 
 
Introduction 
  
Every year in the United States an estimated 1.5 to 2 million people 
sustain traumatic brain injury (TBI). Despite the progress in diagnostics and 
surgical treatments and rehabilitation care, most patients suffer from persistent 
physical and psychological impairments. An efficacious neuroprotective 
compound is yet to be developed in TBI clinical trails to prevent secondary 
neurodegeneration and chronic neurological functional impairment. The primary 
mechanical TBI leads to secondary neural cell damage and cell death which is 
proportional to the degree of cognitive or sensory and motor dysfunction. 
Immediate post-traumatic neurochemical changes begin immediately after injury. 
(Katayama, Becker et al. 1990) which include widespread cellular depolarization 
and massive release of the excitatory neurotransmitter, glutamate, resulting in 
calcium (Ca2+) influx through ion channels associated with glutamate receptors. 
Moreover, the disruption in cellular Ca2+ homeostasis leading to intracellular 
overload is to multiple cytotoxic events including ROS production, mitochondrial 
dysfunction, and Ca2+-dependent protease activation as indicated in 
experimental TBI models (Young 1992; Azbill, Mu et al. 1997). As indicated in 
our previous experiments study using the CCI mouse model, the production of 
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the reactive oxygen species (ROS) peroxynitrite (PN), is an early immediate 
post-traumatic event that appears to lead to mitochondrial damage and functional 
failure and calpain over-activation (Chapter2; Deng et al, 2007). Moreover, we 
have shown that early administration of the multi-mechanistic nitroxide 
antioxidant tempol within the first 15 min post-injury can reduce post-traumatic 
PN-mediated oxidative damage, maintain mitochondrial function and lessen 
calpain-mediated cytoskeletal degradation. In the current study, we investigated 
the effect of early tempol to improve neurological recovery and reduce 
neurodegeneration during the first 7 days in the mouse severe controlled cortical 
impact (CCI) TBI model.  
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Materials and Methods 
 
 All the surgical, injury and animal care protocols described below have 
been approved by the University of Kentucky Institutional Animal Care and Use 
Committee, and are consistent with the animal care procedures set forth in the 
guidelines of the U.S. Public Health Service Policy on Humane Care and Use of 
Laboratory Animals. 
 
Mouse Model of Controlled Cortical Impact (Focal) Traumatic Brain Injury 
 Young adult male CF-1 mice (Charles River, Portage, MI) weighing 29-
31g were used in this study. The mice were anesthetized with isoflurane (3.0%), 
shaved, and then placed in a stereotaxic frame (David Kopf Instruments, 
Tujunga, CA). Throughout the surgery, the mice were provided with constant 
isoflurane (SurgiVet, 100 Series) and oxygen (SurgiVet, O2 flowmeter, 0-4Lpm).  
The head was positioned in the horizontal plane of a stereotaxic frame with the 
nose bar set at zero. We firstly produced a 4mm craniotomy lateral to the sagittal 
suture, and centered between lambda and bregma. A cortical contusion was 
produced on the exposed cortex (the anterior-posterior coordinate for the 
epicenter of the injury was  Bregma -2.0mm) using a pneumatically-controlled 
impactor device (Precision System Instruments TBI-0200 Impactor, Lexington, 
KY) similar to that previously described (Sullivan, Bruce-Keller et al. 1999; 
Sullivan, Thompson et al. 1999; Hall, Sullivan et al. 2005) except that the current 
device utilizes a unique contact sensor mechanism that ensures accurate and 
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reliable determination of cortical surface prior to initiating the injury sequence. 
This results in increased accuracy and reproducibility in regards to the CCI injury 
compared to that produced by earlier CCI impactors. In the present studies, the 
impactor containing a 3mm diameter rod tip compressed the cortex at 3.5m/sec 
to a depth of 1mm with a dwell time of 50msec to produce a severe injury. After 
surgery and injury, a 4mm disk made from dental cement (Dentsply Trubyte) was 
placed over the craniotomy site and adhered to the skull using cyanoacrylate. In 
order to prevent immediate post-traumatic hypothermia, following the suturing of 
the skin, mice were placed in a Hova-Bator incubator (37˚C, model 1583, Randall 
Burkey Co) until them regained consciousness (determined by the regain of the 
righting reflex and increased mobility). The injured mice were allowed to survive 
from 7 days. The N for each time point group was 12 animals based upon our 
experience with the variability seen with these measurements in previous studies 
(Kupina, Detloff et al. 2002; Hall, Sullivan et al. 2005). 
 
Tempol Preparation 
 Tempol was purchased from Sigma-Aldrich (Milwaukee, WI, U.S.A) and 
freshly prepared in 0.9% saline before abdominal intraperitoneal (i.p.) injection. 
Animals were administered five i.p. dosages of tempol at 300mg/kg according to 
our dose-response study at 15 min, 3 hrs, 6 hrs, 9 hrs and 12 hrs. Used as 
control to tempol treatment group (injured-tempol), 9% saline was given as 
vehicle to animals (injured-vehicle). Another control group involved sham animal 
with craniotomy but no contusion injury, which was as well treated with vehicle 
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(sham-vehicle). Sham animals treated with tempol (n=12) in the dose-response 
study was tested, and indicated no difference from sham-vehicle group (data not 
shown). There was zero mortality in the current study.  
 
Neuroscore Behavioral Test 
The neuroscore test was used to assess the neurological status of the 
sham and TBI mice at 48 hrs and 7 days post-injury. This test is modified from 
previously described series of tests used for assessing the effects of TBI in the 
rat (McIntosh, Vink et al. 1989), and adapted for mouse (Murai, Pierce et al. 
1998; Raghupathi, Fernandez et al. 1998). In the present study, we employed the 
neuroscore with three components: grid walk (front limb and hind limb), cagetop 
(front limb and hind limb) and lateral pulsion. In preliminary experiments we 
documented that the neuroscore test was able to detect motor deficit induced by 
injury after either moderate (0.5 mm) or severe (1.0 mm) CCI TBI.  In each 
component, the animal can receive a total of 4 points for a maximum high of 12 
points. Gridwalk: In this component, the mice are forced to walk on a metal 
gridwalk and timed for 1 min. An observer, who is unaware of the mouse 
treatment groups, observes the left vs. the right limb 1) for a greater number of 
slips on the right side than the left; 2) for more profound slips on the right side as 
apposed to the left.  The animal can lose a maximum of 1 point for the front and 
1 point for the hind limb for this portion of the motor assessment. Cagetop: In the 
second neuroscore component, there are total of 3 points that the mice can lose 
for visible deficits in hind limb and front limb function each. For hind limb 
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functional assessment, the animal is held by the head and the tail above the grid 
and and then slowly moved down toward the grid as the observer assesses the 
hind limbs for toe splay as well as hind limb extension. For front limb functional 
impairment measurement, the animal is suspended by the tail and lowered 
toward the cage top until he can grab the rungs of the cage top during which he 
is determined how well he extends his arms. Lateral pulsion: For the third 
component of the neuroscore test, the animal is placed on a rubber mat, making 
sure its body is parallel to the corrugations on the mat.  He is then slowly pushed 
back and forth the entire width of the mat.  This is done twice slowly to prime the 
animal. After these two practice trials, the first trial is started with a slow push 
(same speed as for the practice trials) and then accelerated for each subsequent 
trial up to 4 trials. Four points are deducted if the animal rolls at the 1st trial, 3 
points at the 2nd trial, 2 points at the 3rd trial and 1 point at the 4th trial. The animal 
gains all points if he does not roll after 4 trials.  
 
De Olmos Silver Staining Analysis of Neurodegeneration 
 Following the completion of the 7 days post-injury neuroscore test, 
neurodegeneration was examined using the de Olmos aminocupric silver 
histochemical technique as previously described (de Olmos, Beltramino et al. 
1994; Switzer 2000; Hall, Gibson et al. 2005; Hall, Sullivan et al. 2005).  At 7 
days the mice (N=12) were overdosed with sodium pentobarbital (200mg/kg i.p) 
and transcardially perfused with 0.9% sodium chloride, followed by a fixative 
solution containing 4% paraformaldehyde.  Following decapitation, the heads 
 109
were stored in a fixative solution containing 15% sucrose for 24 hrs after which 
the brains were removed, placed in fresh fixative and shipped for histological 
processing to Neuroscience Associates Inc (Knoxville TN). The brains used for 
this study were embedded into one gelatin block (Multiblock® Technology, 
Neuroscience Associates). The block was then frozen and thirteen 35µm coronal 
sections were taken 420µm apart between 1.1mm anterior and 4.4mm posterior 
to bregma, were de Olmos silver-stained to reveal degenerating neurons and 
neuronal processes, and then counterstained with Nuclear Fast Red. The brain 
sections were photographed on an Olympus Provis A70 microscope at 1.25× 
magnification using an Olympus Magnafire digital camera and the image was 
analyzed by Image-Pro Plus (4.0). The percentage area of silver staining for 
each brain section was calculated by dividing the area of ipsilateral hemispheric 
silver staining in each section by the area of the contralateral hemispheric area 
and multiplying by 100. The volume of silver staining in the ipsilateral hemisphere 
as a percentage of the contralateral hemispheric volume was estimated by the 
equation % V = t × Σ % a(s), where % V is percent silver stain volume, t = the 
distance between sections analyzed (420µm) and Σ % a (s) is the sum of percent 
area of silver staining in all sections examined (13 for each brain) (Hall, Sullivan 
et al. 2005). 
 
Lesion Volume Measurement 
 In addition to measuring the volume of neurodegeneration with the 
DeOlmos silver staining method, the brain sections were photographed on an 
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Olympus Provis A70 microscope at 1.25× magnification using an Olympus 
Magnafire digital camera and the lesion volume was analyzed by ImageJ 1.37v 
(NIH) (Michel and Cruz-Orive 1988; Sullivan, Thompson et al. 2000; Pandya, 
Pauly et al. 2007). The percentage area of ipsilateral cortical tissue spared for 
each brain section was calculated by dividing the area in each section by the 
area of the contralateral cortex and multiplying by 100. The volume of the 
ipsilateral cortical spared tissue as a percentage of the contralateral cortical 
volume was estimated by the sum of percent area of spared tissue of all sections 
multiplied by the distance between sections analyzed.  
 
Statistical Analysis 
 For treatment group analyses, we used Statview 5.0 to perform a one-way 
analysis of variance (ANOVA), followed by Student-Newman-Keuls (SNK) post-
hoc analysis to determine the significance of differences between individual the 
non-injured sham group and injured vehicle treated vs. injured tempol treated 
groups. For multiple section analyses, we used Statview 5.0 to perform an 
ANOVA repeated measurement, followed by Student-Newman-Keuls (SNK) 
post-hoc analysis to determine the significance of differences between individual 
sections in the non-injured sham group and injured vehicle treated vs. injured 
tempol treated groups. For the ANOVA, a p<0.05 was required to establish a 
statistically significant difference across the groups. However, for the post-hoc 
SNK analysis, the program determined significance based upon a correction for 
multiple comparisons comparing among groups.  
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Results 
 
Behavioral Outcome Measured by Neuroscore Motor Test after Tempol 
Treatment  
 Five i.p. dosages of tempol (300mg/kg each; last dose at 12 hrs after 
injury) were administered to the animals at a three hours intervals beginning at 
15 min following the CCI injury. Behavioral outcome was assessed at 48 hrs and 
7 days after TBI respectively measured by neuroscore. We divided the scores 
into fore limb and hind limb two categories. At 48 hrs after injury (Figure 4.1), the 
ANOVA revealed a significant difference across the treatment groups in both fore 
limb [F(2,33)=3.610; p<0.05] and hind limb [F(2,33)=3.927; p<0.05] motor 
function. Post-hoc analysis showed that the motor function in injured vehicle-
treated group was significantly impaired compared to the scores of the sham 
group. Although the 48 hrs fore limb and hind limb scores for the injured tempol-
treated group were not significantly different from the injured vehicle-treated 
group, the scores of the tempol-treated group were also not significantly lower 
than the sham group implying some improvement in the 48 hrs neurological 
status as a result of tempol treatment started at 15 min post-injury. At 7 days 
after injury, both fore limb [F(2,33)=2.668; p=0.0843] and hind limb 
[F(2,33)=2.797; p=0.0755] motor function showed no significant difference 
among treatment groups. Although injured vehicle-treated animals showed 
decreased scores comparing to sham group, this slight deficit was not statistically 
significant.  
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Figure 4.1 Behavioral outcome of multiple dose tempol treatment measured by 
neuroscore motor test after TBI. Neuroscore was accessed at 48 hrs and 7 days 
after injury. N = 12 animals per treatment group; values = mean + standard error; 
one-way ANOVA and Student-Newman-Keuls post hoc test: A p < 0.05 vs. sham; 
one-way ANOVA and Student-Newman-Keuls post hoc test:  
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Histological Evaluation of Neurodegeneration Measured by de Olmos 
Aminocupric Silver Staining after Tempol Treatment 
Following the 7 day neuroscore test, the brains were harvested for 
histopathological analysis of neurodegeneration.  Figure 4.2 displays the degrees 
of cortical tissue sparing (4.2A) and hemispheric neurodegeneration (4.2B) in 
injured, vehicle-treated and injured tempol-treated animals. Figure 4.2A 
measured the spared tissue in vehicle-treated vs. tempol-treated animals. The 
area of spared tissue in ipsilateral cortex was outlined and calculated as 
percentage of the area of contralateral cortex. In Figure 4.2A, tempol-treated 
group showed 5% improvement in spared cortical tissue volume compared to 
vehicle-treated group, however, the increase was not quite significant. Using the 
de Olmos aminocupric silver staining method, we are able to measure 
degenerating tissue in the entire ipsilateral hemisphere plus the ipsilateral lesion 
volume. In Figure 4.2B, both injured groups displayed a significant increase in 
neurodegeneration silver staining volume compared to sham group. However, 
the injured tempol-treated group showed significantly reduced neurodegeneration 
compared to injured vehicle-treated group [F(2,33)=125.864; p<0.05]. In Figure 
4.2C, selected coronal brain section in the epicenter displayed the improvement 
in tissue sparing as well as the reduction in the volume of neurodegeneration-
related silver staining with tempol treatment vs. vehicle treatment.  
Figure 4.3 shows the percentage of silver staining in coronal brain 
sections from the anterior hemispheric boundary of the post-traumatic 
neurodegeneration to the posterior boundary. Injured groups at all sections 
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showed a significant increase of silver staining compared to the sham group. The 
injured, tempol-treated group displayed significantly less silver staining than 
injured vehicle-treated group at section 28, which is in the epicenter of the injury.  
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Figure 4.2 Histological evaluation of multiple dose tempol treatment on tissue 
sparing and silver staining in ipsilateral hemisphere after TBI. A. Tissue sparing 
at 7 days after injury showed slight increase in tempol treatment group, however, 
not significant. B. Silver staining at 7 days after injury indicated significant 
reduction of silver staining in tempol treatment group. C. Selected coronal brain 
sections in the epicenter from different treatment groups. N = 12 animals per 
treatment group; values = mean + standard error; one-way ANOVA and Student-
Newman-Keuls post hoc test: A p < 0.05 vs. sham; one-way ANOVA and 
Student-Newman-Keuls post hoc test: B p < 0.05 vs. vehicle. 
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Figure 4.3 Histological evaluation of multiple dose tempol treatment on coronal 
brain section silver staining in ipsilateral hemisphere after TBI. Silver staining at 7 
days after injury indicated significant reduction of silver staining in tempol 
treatment group at coronal section 28. N = 12 animals per treatment group; 
values = mean + standard error; repeated measures ANOVA and Student-
Newman-Keuls post hoc test: A p < 0.05 vs. sham; repeated measuers ANOVA 
and Student-Newman-Keuls post hoc test: B p < 0.05 vs. vehicle. 
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Discussion 
 
 In the current study, we tested the hypothesis that tempol, by scavenging 
ROS, preserving mitochondrial function and reducing calpain-mediated 
proteolysis (Chapter 3) could reduce post-traumatic neurological impairment and 
neurodegeneration. There is compelling evidence for the key role of ROS-
induced oxidative damage in the secondary injury in TBI models (Kontos and 
Povlishock 1986; Kontos and Wei 1986; Hall, Andrus et al. 1993; Hall, Andrus et 
al. 1994; Smith, Andrus et al. 1994; Globus, Alonso et al. 1995). Most convincing 
is the fact that several antioxidant compounds have been shown to be 
neuroprotective in TBI models (Hall and Smith 1991; Marshall, Maas et al. 1998; 
Mori, Kawamata et al. 1998; Marklund, Lewander et al. 2001). However, most 
antioxidants are targeting one specific free radical and react stoichiometrically.  
As indicated in our first study (Chapter 2), PN is probably the key mediator 
in post-traumatic oxidative damage, which is the main source for both lipid 
peroxidation and protein nitration (Deng, Thompson et al. 2007). Tempol, a PN-
derived free radical scavenger, is a membrane permeable, catalylic antioxidant, 
which was shown to react promptly with hydroxyl radical, nitrogen dioxide and 
carbonate radical (Carroll, Galatsis et al. 2000; Bonini, Mason et al. 2002). 
Moreover, PN as an upstream factor in the secondary injury cascade, we proved 
that tempol was able to inhibit oxidative damage, ameliorate mitochondrial 
dysfunction and decrease calpain-mediated cytoskeletal degradation at least 
when administered during the first 15 min post-injury. Therefore, in the present 
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study, we further examined the ability of tempol to exert a definitive 
neuroprotective effect in terms of a reduction in neurological impairment and 
neurodgeneration.  
We applied de Olmos aminocupric silver staining in this study to measure 
neurodegeneration. Comparing to conventional histological staining used in 
many pathohistological studies, the silver staining method is much more sensitive 
in detection of injured neurons and axons in response to TBI (de Olmos, 
Beltramino et al. 1994; Switzer 2000). At 7 days after injury, severe cavitation 
has developed at the epicenter of the contusion. However, silver staining 
revealed subcortical tissue damage widespread to ipsilateral hippocampus and 
dorsolateral thalamus. Moreover, silver staining disclosed commissural fiber 
damage extended to the contralateral site to the injury. Therefore, silver staining 
is able to detect cellular damage that is not measured by conventional 
histological staining. Spared tissue volume showed no significant difference 
between vehicle and tempol treatment. However, measurement of silver staining 
revealed a significant, but rather modest reduction in neurodegeneration after 
tempol treatment.  
Despite the improvement in overall neurodegeneration, there was no 
significant functional recovery after the tempol treatment measured by 
neuroscore at 7 days after injury. The current neuroscore motor test was 
examined in a pilot study. At 48 hrs and 72 hrs after severe (1.0mm) and 
moderate (0.5mm) CCI in mouse, animals showed significant deficit comparing to 
sham animals (data not shown). At 48 hrs, severe TBI mice displayed further 
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impairment than moderate TBI mice. However, at 72 hrs, both severe and 
moderate TBI mice scored similarly. In the current study, we accessed the 
neuroscore of the mice at 48 hrs and 7 days respectively. The deficit was 
detectable in both fore limb and hind limb motor function at 48 hrs after injured 
with vehicle treatment, but not at 7 days. Nevertheless, the tempol treatment did 
appear to exert some improvement in neurological recovery at the 48 hrs time 
point. Although the tempol group did not manifest a significant difference 
compared to the neuroscore of the vehicle treatment group, neither the fore limb 
nor the hind limb functional scores were significantly differently from sham group 
in contrast to the significantly lower scores in the injured, vehicle-treated mice 
compared to the sham group. This suggested that motor function was somewhat 
improved with the tempol treatment. At 7 days after injury, we accessed the 
neuroscore again. However, scores in all groups were similar and there was no 
significant difference among groups. We suspect that the current neuroscore test 
may not be suitable for long-term behavioral evaluation. In any event, the 
beneficial effects of tempol also demonstrated previously in a rat TBI model (Beit-
Yannai, Zhang et al. 1996; Zhang, Shohami et al. 1998) and in cerebral ischemia 
models (Rak, Chao et al. 2000; Leker, Teichner et al. 2002) are consistent with 
the view that the compound possesses demonstrable neuroprotective properties 
in CNS injury models, in general.    
There may be multiple reasons for the modest effect of tempol. First of all, 
the testing of tempol for its ability to reduce calpain-mediated cytoskeletal 
degradation which was assessed at 24 hrs after injury (Chapter 3), showed a 
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statistically significant 45% reduction in calpain-mediated cytoskeletal 
degradation. We suspect that the partial inhibition of calpain-mediated proteolysis 
is part of the reason why tempol did not have more pronounced effect in 
preserving neuronal tissue. Secondly, in the present experiments, 
neurodegeneration was not examined until 7 days after injury rather than at its 
peak which is 48 hrs post-injury (Chapter 2; Deng, Thompson et al. 2007). This 
was done so that we could assess neurological status out to 7 days before 
performing histopathology. However, the 7 day time point where less silver 
staining is seen compared to the 48 hrs peak may make it more difficult to 
observe a more robust neuroprotective effect. Thirdly, as noted in Chapter 3, the 
half life of tempol in mice is fairly short (i.e. <30 min) (Kamatari, Yasui et al. 2002) 
and therefore even repeated dosing with the compound is unable to maintain 
therapeutic levels adequately during the first 12 hrs post-injury. Other longer-
acting PN-directed antioxidants may be more effective due to the ability to 
maintain a steady, non-fluctuating radical scavenging effect. Lastly, even though 
PN-mediated oxidative damage is an important player in the secondary injury 
process, a more complete neuroprotective effect may require simultaneously 
blocking the secondary injury cascade at multiple points downstream from the 
early oxidative damage with a mitochondrial protective agent and/or a direct 
inhibitor of calpain.   
 Concerning the latter option, the principle pathological role of calpain-
mediated proteolysis is demonstrated in secondary neuronal cell death (Buki, 
Siman et al. 1999; Povlishock, Buki et al. 1999; Kupina, Detloff et al. 2003; Hall, 
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Sullivan et al. 2005). Calpain is a calcium-dependent protease and is triggered in 
response to massive calcium influx following TBI (Saatman, Graham et al. 1998; 
Kupina, Detloff et al. 2003; Serbest, Burkhardt et al. 2007). Immuno-detection of 
structural protein spectrin, which is a substrate for calpain, showed calpian-
mediated proteolysis in damaged axons (Roberts-Lewis, Savage et al. 1994). In 
addition to spectrin, other structural proteins, such as microtubule associated 
proteins (MAPs) and neurofilaments (NFs) are also substrates for calpain, and 
are associated with axonal damage (Maxwell, Povlishock et al. 1997; Okonkwo, 
Pettus et al. 1998). Therefore, calpain is a logical therapeutic target for 
pharmacological inhibition in combination with an antioxidant in order to more 
completely prevent post-traumatic neurodegeneration. Indeed, several calpain 
inhibitors administered either prior to or after CNS injury (Saatman, Murai et al. 
1996; Kupina, Nath et al. 2001; Kupina, Detloff et al. 2002; Buki, Farkas et al. 
2003) have been shown to improve post-traumatic neurological recovery and 
tissue sparing.  
In conclusion, despite the possibly limited therapeutic potential of tempol 
by itself, the protective efficacy of the compound is at least adequate to support 
our original hypothesis that PN-mediated oxidative damage is an upstream post-
traumatic event that contributes to mitochondrial dysfunction, intracellular Ca2+ 
overload, calpain-mediated cytoskeletal degradation and neurodegeneration as 
illustrated in Figure 4.4. Copyright © Ying Deng 2007.  
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Figure 4.4 Hypothetical interrelationship between PN-induced oxidative damage 
in neuronal mitochondria and the compromise of Ca2+ homeostasis, calpain-
mediated proteolysis and neurodegeneration. Our results suggest that the potent 
antioxidant, tempol, by targeting the upstream PN-derived free radicals, produces 
cascades of effects on the downstream cellular elements, such as preserve 
mitochondrial function, ameliorate Ca2+ overload, reduce calpain-mediated 
proteolysis and neurodegeneration. 
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Chapter Five 
Summary and Conclusions 
 
 Traumatic brain injury (TBI) is comprised of the primary injury and 
secondary injury. The initial mechanical assault to the head induces instant 
tissue damage, which is termed the primary injury. However, the primary injury 
induces cascades of neurochemical changes, which lead to further neuronal cell 
loss, microvascular damage and dysfunction and impairment in behavioral 
function. Secondary injury begins immediately after injury, and this post-injury 
phase may last for days and weeks depending on the severity of the initial injury. 
Although little can be done to reduce the primary injury apart from decreasing the 
risk of TBI, it is feasible to ameliorate post-TBI secondary injury by timely 
pharmacological intervention. Thus, understanding pathological mechanisms 
responsible for post-traumatic neuronal damage will shed light on 
neuroprotective pharmaceutical approaches.  
Successful pharmacological interventions for TBI patients are not 
available to this day due in large part to the complexity of the neurological 
changes initiated by the primary injury. In this series of studies, we employed a 
widely used focal TBI model, controlled cortical impact (CCI) mouse model. The 
current project has identified peroxynitrite (PN) as an important therapeutic target 
for pharmacological intervention. Moreover, we explored the effect of PN-derived 
radical scavenger, tempol, on PN-induced oxidative damage, mitochondrial 
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dysfunction, calpain-mediated proteolysis, neurodegeneration and neurological 
outcome. 
 The first study is a thorough comparative time course assessment of PN-
induced oxidative damage, calpain-mediated α-spectrin breakdown and 
neurodegeneration measured by de Olmos aminocupric silver staining in 
ipsilateral cortex in the CCI mouse model. Both quantitative slotblotting and 
immunohistochemical studies indicate that PN is the main source of lipid 
peroxidation and protein nitration, suggesting that PN is an important mediator of 
post-traumatic oxidative damage. The onset of PN-mediated oxidative damage 
measured in cerebral cortical tissue begins immediately after injury and peaks at 
1 hr after injury. This is coincident with an increase of oxidative damage in 
cortical mitochondria, suggesting that mitochondria are perhaps the main source 
and target of post-traumatic production of PN. Furthermore, quantitative 
westernblotting measured calpain-mediated cytoskeletal degradation which is 
also increased within the first hours after injury. The increased appearance of 
calpain-mediated spectrin breakdown (SBDPs) progresses over time and 
reaches its peak at 24 hrs. Calpain-specific SBDP145 showes a much higher 
magnitude than non-specific calpain/caspase 3-generated SBDP150, indicating 
that calpain is the main mediator in post-traumatic proteolysis. Moreover, the 
peak of calpain-mediated cytoskeletal breakdown precedes the peak of 
neurodegeneration, which is at 48 hrs after injury.  
 The time course study elegantly illustrated the interrelationship of several 
key mediators following TBI. The early increase of PN production correlates with 
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mitochondrial dysfunction. As a key calcium buffer in the cell, the loss of 
mitochondrial function exacerbates Ca2+-dependent calpain activity, and 
eventually neuronal cell loss. The quantitative measurement of the end products 
of oxidative damage and calpain-mediated proteolysis also provides measurable 
index for therapeutic studies. More importantly, the complete temporal profile of 
oxidative damage, calpain activity and neurodegeneration defines the probable 
time windows for pharmacological intervention. These results reveal that PN is 
an upstream event that precedes mitochondrial dysfunction, calpain over-
activation and neurodegeneration. Therefore, targeting PN-induced oxidative 
damage may have multiple beneficial effects through inhibition of several key 
mediators in the secondary injury process. However, the extremely early peak of 
oxidative damage also makes it a difficult target. Timely treatment is critical in 
therapeutic interventions. Based on the time course study, we chose the optimal 
time point of each end point for neuroprotective effect evaluation.   
 To test the hypothesis that blockade of upstream PN-induced oxidative 
damage will produce a neuroprotective effect, we pharmacologically targeted PN 
using a potent antioxidant, tempol, in the CCI model. Tempol is a membrane 
permeable, catalytic scavenger of PN-derived free radicals. In an initial study, we 
examined the dose-response of tempol in regards to an inhibitory effect on PN-
induced oxidative damage across a three log range of dosages (3, 10, 30, 100 
and 300mg/kg i.p.). We chose the PN-specific marker, 3-nitrotyrosine (3NT), as 
an index to examine the effect of tempol on PN-induced oxidative damage. In 
order to achieve maximal effect, tempol was administered i.p. at 15 min and 
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tissue was harvested at 1 hr post-injury when oxidative damage is at its peak. 
Our results show that tempol inhibited PN-mediated oxidative damage in a dose-
related manner with the highest dose levels of 30, 100 and 300mg/kg each 
producing a statistically significant effect. Moreover, quantitative slotblotting 
measurement of 3NT indicated that at 300mg/kg, tempol reduces 3NT to sham 
level. This study demonstrated that tempol is an effective inhibitor of PN-
mediated oxidative damage in the injured brain.  
 Following the success of tempol in inhibition of PN-induced oxidative 
damage, we chose the optimal dose (300mg/kg) of tempol in the subsequent 
studies to confirm our hypothesis that oxidative damage is the upstream element 
in the secondary injury cascade. We hypothesizes that mitochondria are the main 
source of PN production based upon previous studies in our laboratory showing 
that PN-mediated damage occurs in mitochondria from the injured brain which 
parallels the loss of respiratory function and Ca2+-buffering capacity. Indeed, in 
response to glutamate-induced excitotoxic calcium influx, mitochondrial Ca2+ 
uptake induces superoxide and nitric oxide radical production, which can 
combine with a diffusion rate-limited rate constant to produce PN. To test the 
association between mitochondrial PN oxidative damage and respiratory 
dysfunction, we administered tempol 15 min after injury and isolated the 
mitochondria from the injured cerebral cortex at 12 hrs post-injury. Using Clarke-
type electrode measurement of mitochondrial respiration, tempol-treated 
mitochondria show improved maintenance of respiratory function together with 
reduced oxidative protein damage. The protective effect of tempol on 
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mitochondrial function reveals that: 1) tempol is membrane permeable and 
effective in penetrating into mitochondrial matrix; 2) mitochondria are a main 
source for PN production as well as the primary target of PN-mediated oxidative 
damage. Moreover, the success of using tempol in vivo to preserve mitochondrial 
function, strongly suggests that PN plays a significant role in mediating 
mitochondria calcium influx-induced functional impairment. 
 Moving downstream in the hypothesized secondary injury cascade, we 
examined the effect of tempol on calcium-dependent calpain activity. Calpain is 
activated upon calcium influx and is shown to play an important role in 
cytoskeletal degradation, which is considered as a final common pathway to cell 
death. Because of the close relationship of calpain and cytosolic calcium level, 
we hypothesize that tempol, by preserving mitochondrial function and 
maintaining calcium homeostasis, will indirectly attenuate calpain activity. To test 
this hypothesis, we administered single i.p. dose of tempol 15 min after injury and 
evaluated calpain-mediated SBDPs at 1 hr and 6 hrs post-injury measured by 
quantitative slotblotting. The results demonstrate that tempol significantly 
reduces calpain-specific SBPD145 at 1 hr but not at 6 hrs after injury. The 
inhibitory effect of antioxidant tempol on calpain-mediated cytoskeletal 
proteolysis strongly confirms that PN-induced oxidative damage is upstream to 
calpain over-activation. However, the effect of tempol on calpain activity is short-
lived possibly due to the high elimination rate of tempol in the mouse brain. 
Therefore, we explored the effect of a multiple dose regimen with tempol on 
calpain-mediated cytoskeletal degradation. In the tempol multiple dose 
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experiment, we administered tempol 300 mg/kg i.p. to animals at 15 min, 3 hrs, 6 
hrs, 9 hrs and 12 hrs post-injury and harvested the tissue at 24 hrs, when 
calpain-mediated SBDPs are at their peak. This dosing regimen was designed to 
maintain an inhibition of PN-mediated oxidative damage over its full time course 
of 12 hrs based upon our original time course studies. Our results show tempol 
significantly reduces SBDPs by 45% at 24 hrs post-injury. Although the 
prolonged treatment with tempol may have successfully inhibited most of the 
oxidative damage, the inhibition of calpain activity was only partial. A possible 
explanation is that PN itself has inhibitory effect on both calpain and caspase 3 
by oxidizing cysteine residues on their active site. Therefore, the complete 
inhibition of PN may partially antagonize the full expression of its protective 
benefits via a removal of an oxidative break on calpain activity.   
 We then did a tempol therapeutic window study by measuring calpain-
mediated SBDPs. We used the same multiple dosing regimen, but delayed 
treatment by 1 hr and 2 hrs. In this study, we are not able to observe any 
beneficial effect of tempol on calpain inhibition. It is possible that the first hour 
window is crucial for PN-induced oxidative damage and tempol alone may not be 
able to induce maximal inhibition on calpain activity.  
 We have successfully proven that by preventing upstream PN-induced 
oxidative damage, we can ameliorate mitochondrial dysfunction and attenuate 
calpain-mediated cytoskeletal degradation, which is linked to cell injury and 
death. Therefore, we applied the multiple dosing regimen and examined the 
neurodegeneration at 7 days after injury. In this study, we measured ipsilateral 
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cortical tissue spared volume and ipsilateral hemispherical silver staining volume. 
Tempol treatment increases cortical tissue sparing. However, this effect is not 
significant compared to vehicle-treated group. In contrast, silver staining detected 
a significant decrease in neurodegeneration in tempol-treated group. In the 
tempol-treated group, the extent of the silver staining is reduced. We believe that 
silver staining is a much more sensitive technique that more accurately reveals 
the degree of post-traumatic tissue damage and more sensitively shows the 
efficacy of neuroprotective agents.  
 In this last study, we examined the behavioral outcome in parallel with the 
neurohistological study. Specifically, we measured motor function of the TBI mice 
at 48 hrs and 7 days post-injury. At 48hrs, we observed a deficit in motor function 
in the injured vehicle-treated animals. However, the mean score of the tempol-
treated animals is not significantly different from either the non-injured sham 
group or vehicle-treated group. At 7 days, the neuroscore is not able to detect 
any difference among the groups suggesting that future studies should focus on 
the earlier 48 hrs time point. Moreover, a more sensitive functional test, or a 
combination of different behavioral assessment, such as cognitive as well as 
motorsensory testing, should be considered in the future. 
 In summary, the complete time course study and the pharmacological 
study compliments each other, and provide strong evidence for PN-induced 
oxidative damage being an important upstream mediator in the secondary cell 
death cascade. In our study, scavenging PN-derived free radicals with the 
nitroxide antioxidant tempol produces beneficial effects on mitochondrial function 
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and probably calcium buffering capacity which in turn reduces downstream 
calpain-mediated proteolysis and neurodegeneration. However, the complexity of 
the secondary injury process after TBI challenges the idea that single therapy 
can achieve optimal neuroprotection and improvement in functional outcome. In 
the future, it will make sense to investigate combination therapies that 
simultaneously target PN-induced oxidative damage along with either inhibition of 
mitochondrial permeability transition or calpain activation or both. Copyright © 
Ying Deng 2007.  
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Appendix I 
 
 
 
Figure A.1 Time course of mitochondrial states III & IV respiratory rates in 
mouse ipsilateral cortex after severe (1.0mm) TBI. Mitochondrial oxygen 
consumption was measured using a Clark-type electrode in a continuously 
stirred, sealed chamber (Oxygraph System; Hansatech Instruments Ltd). Purified 
mitochondrial protein (25 to 35 µg) was suspended in respiration buffer 
(125mmol/L KCl, 2mmol/L MgCl2, 2.5mmol/L KH2PO4, 0.1% BSA, 20mmol/L 
HEPES, pH7.2) in a final volume of 250µl. Data are presented as mean ± s.e.m. 
Statistical differences (one-way ANOVA and Student-Neuman-Keuls post hoc 
test): * P<0.0001 versus sham; # P<0.001 versus sham. 
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Appendix II 
 
 
 
Figure A.2 Time course of lipid (HNE) and protein (protein carbonyl) oxidative 
damage in percoll-purified mitochondria from the ipsilateral cortex after a severe 
(1.0mm) TBI. Distribution of HNE, protein carbonyls, and 3NT in cortical 
mitochondria from mice at 30 min, 3 and 12 hrs after injury and were compared 
with sham (3 hrs) animals. Approximately 2.5µg of percoll-purified mitochondrial 
protein isolated from cortical region was applied onto Protran nitrocellulose 
membrane (Schleicher & Schuell, Dassel, Germany), as described in Materials 
and Methods, and oxidative markers were quantitated using a Minifold II 
vacuum slot blot apparatus. Data are presented as mean ± s.e.m. Statistical 
differences (one-way ANOVA and SNK post hoc test): * P<0.05 versus sham; ** 
P<0.001 versus sham; *** P<0.0001 versus sham; @ P<0.005 versus sham. 
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Appendix III 
 
Glossary of important terms 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
∆Ψm mitochondrial membrane 
potential  
∆pH  proton force  
3NT  3-nitrotyrosin 
4HNE  4-hydroxynonenal 
8-OH-G 8-hydroxyguanine  
8-OHdG 8-
hydroxydeoxyguanosine 
ADP  adenosine diphosphate  
AIF  apoptosis inducing factor 
ANT adenine nucleotide 
translocator 
ASDH  subdural hematoma  
ATP  adenosine triphosphate  
BBB  blood-brain barrier 
BDPs  breakdown products  
Ca2+  calcium 
CCI  controlled cortical impact  
CNS  central nervous system 
CsA  cyclosporine A 
CypD  cyclophilin D 
Cyt c  cytochrome c 
DNPH 2,4-
dinitrophenylhydrazine  
eNOS epithelial nitric oxide 
synthase 
ETC  electron transport chain 
FADH2 reduced flavin adenine 
dinucleotide  
FCCP p-trifluoromethoxy 
carbonyl cyanide phenyl 
hydrazone 
FMNH2 reduced flavin 
mononucleotide  
FPI  fluid percussion injury  
GPX  glutathione peroxidase 
GSH  glutathione  
HPLC high-performance liquid 
chromatography 
IMM inner mitochondrial 
membrane  
 
iNOS inducible nitric oxide 
synthase 
L-DOPA dihydroxyphenylalanine  
LP lipid peroxidation 
NADPH nicotinamide adenine 
dinucleotide phosphate, 
reduced form  
nNOS neuronal nitric oxide 
synthase 
MAP2 microtubule-associated 
proteins 
MDA  malondialdehyde  
mPTP mitochondrial 
permeability transition 
pore  
MPTP 1-methyl-4-phenyl-1,2,5,6 
tetrahydropyridine  
mtNOS mitochondrial nitric oxide 
synthase 
NADH nicotinamide adenine 
dinucleotide, reduced 
form  
NADPH nicotinamide adenine 
dinucleotide phosphate, 
reduced form 
NF  neurofilament 
NMDA N-Methyl-D-aspartate  
NO  nitric oxide 
NOS  nitric oxide synthas  
ONOO• peroxynitrite anion 
ONOO⎯ peroxynitrite anion 
ONOOH peroxynitrite acid 
ONOOCO2 nitrosoperoxo carbonate 
PARS ADP-ribose synthetase  
PBS phosphate-buffered 
saline 
PGH prostaglandin 
hydroperoxidase 
PN  peroxynitrite  
PUFAs polyunsaturated fatty 
acids 
 134
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RCR  respiratory control ratio  
ROS  reactive oxygen species 
RNS  reactive nitrogen species 
SBDPs α-spectrin breakdown 
products 
SCI  spinal cord injury  
SOD  superoxide dismutase 
XO xanthine oxidase 
TAI  traumatic axonal injury 
TBI  traumatic brain injury  
TBS  tris-buffered saline  
UCPs  uncoupling proteins 
UQ  ubiquinone 
UQ• ⎯ semiquinone anion 
species 
UQH2  ubiquinol 
XDH  xanthine dehydrogenase 
XO  xanthine oxidase 
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